Utilizamos cookies

Este sitio web utiliza cookies propias y de terceros para mantener la sesión, ofrecerle una mejor experiencia de usuario y obtener datos estadísticos de navegación de los usuarios. Para más información vea la Política de cookies.

Ver Investigador - - Prisma - Unidad de Bibliometría

Manuel Romero Gómez

Catedrático de Universidad (Pza. V.)
mromerogomez@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: UNIDAD DE HEPATOLOGIA - CTS-532 (Sistema Sanitario Público de Andalucía. Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI))
Prog. doctorado: Prog.Doct.en Biología Molecular, Biomedicina e Investigac.Clínica (RD.2011)
Tipo Año Título Fuente
Artículo2024 A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death Scientific reports
Artículo2024 A multisociety Delphi consensus statement on new fatty liver disease nomenclature ANNALS OF HEPATOLOGY
Short Survey2024 Accuracy, Reliability, and Comprehensiveness of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Revisión2024 Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions JOURNAL OF HEPATOLOGY
Revisión2024 Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance RNA BIOLOGY
Artículo2024 Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score LIVER INTERNATIONAL
Artículo2024 Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio Delphi GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2024 Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease. JOURNAL OF HEPATOLOGY
Editorial2024 Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists Endocrinología, diabetes y nutrición
Revisión2024 Novel insights into metabolic-associated steatotic liver disease preclinical models LIVER INTERNATIONAL
Artículo2024 Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding JOURNAL OF HEPATOLOGY
Artículo2024 Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease GUT
Artículo2024 Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF) HEPATOLOGY
Artículo2024 Trombocitopenia grave asociada a enfermedad hepática crónica en España: resultados de un estudio retrospectivo utilizando aprendizaje automático y procesamiento de lenguaje natural GASTROENTEROLOGIA Y HEPATOLOGIA
Revisión2023 A multisociety Delphi consensus statement on new fatty liver disease nomenclature JOURNAL OF HEPATOLOGY
Artículo2023 A multisociety Delphi consensus statement on new fatty liver disease nomenclature HEPATOLOGY
Artículo2023 A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease JOURNAL OF HEPATOLOGY
Letter2023 A second update on mapping the human genetic architecture of COVID-19. NATURE
Short Survey2023 AEEH «Consensus about detection and referral of hidden prevalent liver diseases» GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2023 Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode. LIVER INTERNATIONAL
Artículo2023 An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography. JOURNAL OF HEPATOLOGY
Artículo2023 An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease Hepatobiliary Surgery and Nutrition
Artículo2023 An international multidisciplinary consensus statement on MAFLD and the risk of CVD HEPATOLOGY INTERNATIONAL
Resumen congreso2023 Analysis of the diagnostic accuracy of the non-invasive fibrosis indices NFS, HFS, and FIB-4 in the staging of advanced fibrosis in patients with metabolic fatty liver: meta-analysis of comparative studies JOURNAL OF HEPATOLOGY
Resumen congreso2023 At- risk nash identification using an algorithm that combines fib-4+masef ( metabolomicsadvanced steatohepatitis fibrosis score) HEPATOLOGY
Artículo2023 Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study LANCET GASTROENTEROLOGY & HEPATOLOGY
Resumen congreso2023 Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD) JOURNAL OF HEPATOLOGY
Artículo2023 Biomimetic superabsorbent hydrogel acts as a gut protective dynamic exoskeleton improving metabolic parameters and expanding A. muciniphila Cell Reports Medicine
Artículo2023 Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis. Biomarker Research
Artículo2023 Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease JHEP Reports
Artículo2023 Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™ JOURNAL OF VIRAL HEPATITIS
Revisión2023 Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: From diagnosis to prognosis ANNALS OF HEPATOLOGY
Resumen congreso2023 Clinical utility of liver and spleen elastography in the management of patients living with liver disease HEPATOLOGY
Artículo2023 Clinical utility of urinary gluten immunogenic peptides in the follow-up of patients with coeliac disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Resumen congreso2023 Clinically significant pruritus in patients with chronic liver disease (CLD): data from the global liver registry™ (GLR™) GASTROENTEROLOGY
Artículo2023 Co-08. Utilidad clínica de la elastografía hepática y esplénica en el manejo de pacientes que viven con enfermedad hepática Revista Andaluza de Patología Digestiva
Artículo2023 Co-10. La relevancia y realidad de la monitorización de la enfermedad mineral ósea en la colangitis biliar primaria Revista Andaluza de Patología Digestiva
Artículo2023 Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas» GASTROENTEROLOGIA Y HEPATOLOGIA
Corrección2023 Corrigendum to “Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis” (Journal of Hepatology (2023) 79(4) (967–976), (S0168827823003513), (10.1016/j.jhep.2023.05.022)) JOURNAL OF HEPATOLOGY
Corrección2023 Corrigendum to “EASL clinical practice guidelines on the management of hepatic encephalopathy” [J Hepatol 2022 (77) 807–824](S0168827822003464)(10.1016/j.jhep.2022.06.001) JOURNAL OF HEPATOLOGY
Resumen congreso2023 Development and validation of a new imaging biomarker combining demili and mre to identify at risk nonalcoholic steatohepatitis ( at- risk nash) patients HEPATOLOGY
Artículo2023 Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis JOURNAL OF HEPATOLOGY
Resumen congreso2023 Development and validation of the AMMON-OHE model to risk stratify cirrhotic outpatients for ocurrence of overt hepatic encephalopathy JOURNAL OF HEPATOLOGY
Artículo2023 Dr. José Aguilar Reina Revista Andaluza de Patología Digestiva
Editorial2023 Editorial: Feeling better about NASH-Authors' reply ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Resumen congreso2023 Efficacy and safety of efinopegdutide in hispanic patients with nonalcoholic fatty liver disease: results from an active comparator-controlled study HEPATOLOGY
Resumen congreso2023 Efficacy of efinopegdutide in nonalcoholic fatty liver disease: subgroup analyses from an active-comparator-controlled study HEPATOLOGY
Resumen congreso2023 Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD) JOURNAL OF HEPATOLOGY
Artículo2023 Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19 EUROPEAN JOURNAL OF EPIDEMIOLOGY
Resumen congreso2023 Glutaminolysis and Steatosis to Steatohepatitis Transition: Role of Glutaminase AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2023 Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding GUT
Resumen congreso2023 Hepcityfree/ spanish alliance for viral hepatitis elimination: the commitment of spanish cities for hepatitis c elimination HEPATOLOGY
Resumen congreso2023 Identification of new serological biomarkers for the detection of significant fibrosis HEPATOLOGY
Artículo2023 Identification of Potential miRNA-mRNA Regulatory Axis of Intrahepatic cccDNA in Patients with Chronic Hepatitis B Virus Infection in the Grey Zone HEPATITIS MONTHLY
Artículo2023 Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with nonalcoholic fatty liver disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2023 Impact of Type 2 diabetes and obesity on quality of life in non-alcoholic fatty liver disease INTERNATIONAL JOURNAL OF PSYCHOLOGY
Artículo2023 Impacto de la enseñanza integrada de la patología médico-quirúrgica en pequeños grupos basada en la resolución de problemas en el aprendizaje de la medicina Innova medica: revista de innovación docente de la Facultad de Medicina de Sevilla
Artículo2023 Improved health-related quality of life with semaglutide in people with non-alcoholic steatohepatitis: a randomised trial. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2023 Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) a randomised, double-blind, phase 3 trial LANCET ONCOLOGY
Artículo2023 Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Artículo2023 Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol Contemporary Clinical Trials
Artículo2023 Liver stiffness accuracy by MR elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort Revista Española de Enfermedades Digestivas
Artículo2023 Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis GUT
Resumen congreso2023 Longitudinal study of nafld progression using paired biopsies in a well-characterised european cohort HEPATOLOGY
Artículo2023 Looking for the best algorithm in the diabetes population for advanced fibrosis detection: The best is the enemy of the good. HEPATOLOGY
Artículo2023 Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: a development and validation study HEPATOLOGY
Artículo2023 Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity FASEB JOURNAL
Revisión2023 Metabolic dysfunction: The silenced connection with fatty liver disease ANNALS OF HEPATOLOGY
Artículo2023 Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes HUMAN MOLECULAR GENETICS
Artículo2023 Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis CELL DEATH & DISEASE
Resumen congreso2023 Non-alcoholic fatty liver disease (nafld) is associated with significant impairment of work productivity: data from the global nash registry™ HEPATOLOGY
Capítulo2023 Non-pharmacological treatment approach in patients with metabolic dysfunction-associated liver disease Comprehensive Guide to Hepatitis Advances
Artículo2023 Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention BMJ-BRITISH MEDICAL JOURNAL
Artículo2023 Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease JHEP Reports
Artículo2023 Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver. Revista Española de Enfermedades Digestivas
Artículo2023 Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis LANCET GASTROENTEROLOGY & HEPATOLOGY
Artículo2023 Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2023 Potent and polyfunctional hepatitis b core (hbc)/surface (hbs)-specific cd8+and cd4+t cell responses observed in adults with chronic hepatitis b (chb) following targeted immunotherapy consisting of viral vectors in heterologous prime-boost regimen and adjuvanted hbc/hbs proteins: results on step b cohort of a phase i/ii trial HEPATOLOGY
Artículo2023 Predicting liver-related events in NAFLD: A predictive model HEPATOLOGY
Resumen congreso2023 Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced nonalcoholic fatty liver disease DIGESTIVE AND LIVER DISEASE
Artículo2023 Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice JHEP Reports
Revisión2023 Research priorities for precision medicine in NAFLD CLINICS IN LIVER DISEASE
Artículo2023 Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study. GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2023 Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria. HEPATOLOGY
Artículo2023 Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD. LIVER INTERNATIONAL
Artículo2023 Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study HEPATOLOGY
Resumen congreso2023 Serial vibration controlled transient elastography (vcte)-based agile scores predict liver-related events in nonalcoholic fatty liver disease (nafld) - a multicenter cohort study of 16,603 patients HEPATOLOGY
Artículo2023 Serum lipidome unravels a diagnostic potential in bile acid diarrhoea. GUT
Resumen congreso2023 Single-cell RNA sequencing in DIAMOND mice reveals differentially regulated pathways specifically associated with the transition from simple steatosis towards NASH JOURNAL OF HEPATOLOGY
Resumen congreso2023 Stigma is a predictor of impairment of health related quality of life among patients with nafld HEPATOLOGY
Artículo2023 Tenofovir disoproxil fumarate reduces the severity of COVID-19 in patients with chronic hepatitis B DIGESTIVE DISEASES AND SCIENCES
Artículo2023 The efficacy and safety of granulocyte colony-stimulating factor in the treatment of acute-on-chronic liver failure: A systematic review and meta-analysis PLOS ONE
Resumen congreso2023 The global survey of disease burden and stigma among patients with nafld and their healthcare providers HEPATOLOGY
Resumen congreso2023 Understanding barriers in non-alcoholic liver disease (nafld) management: insights from a multi-disciplinary survey of physicians in europe (barriers-nafld) HEPATOLOGY
Artículo2023 Update on the Role of Rifaximin in Digestive Diseases Journal of gastrointestinal and liver diseases : JGLD
Resumen congreso2023 What patients with nonalcoholic fatty liver disease should we treat with pharmacological agents? HEPATOLOGY
Artículo2022 A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2022 A cholestatic pattern predicts major liver-related outcomes in patients with nonalcoholic fatty liver disease. LIVER INTERNATIONAL
Artículo2022 A global survey of physicians knowledge about nonalcoholic fatty liver disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Artículo2022 A shortcut from metabolic-associated fatty liver disease (MAFLD) to hepatocellular carcinoma (HCC): c-MYC a promising target for preventative strategies and individualized therapy CANCERS
Artículo2022 A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Revisión2022 Advancing the global public health agenda for NAFLD: a consensus statement Nature Reviews Gastroenterology and Hepatology
Resumen congreso2022 Approaches for a hepatitis C-free city: preliminary results JOURNAL OF HEPATOLOGY
Artículo2022 Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival Viruses
Artículo2022 Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool Biomarker Research
Artículo2022 Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? GUT
Artículo2022 Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis HEPATOLOGY
Resumen congreso2022 Clinical and Patient-Reported Outcome (PRO) profile of patients with Hepatitis B Viral (HBV) infection from the Global Liver Registry (TM) (GLR (TM)) HEPATOLOGY
Artículo2022 Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: data from the global non-alcoholic steatohepatitis (NASH)/ non-alcoholic fatty liver disease (NAFLD) registry CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2022 Confounding factors in diagnostic performance of magnetic resonance elastography for staging liver fibrosis in patients with non-alcoholic fatty liver disease: an individual patient data meta-analysis JOURNAL OF HEPATOLOGY
Revisión2022 Contribution of liver and pancreatic islet crosstalk to β-cell function/dysfunction in the presence of fatty liver Frontiers in Endocrinology
Corrección2022 Correction to: A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure AMERICAN JOURNAL OF GASTROENTEROLOGY
Resumen congreso2022 Depression and emotional distress in patients with Chronic Liver Disease (CLD): data from the Global Liver Registry (TM) (GLR (TM)) HEPATOLOGY
Artículo2022 Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis EUROPEAN JOURNAL OF INTERNAL MEDICINE
Artículo2022 Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis based on Asian data Revista Española de Enfermedades Digestivas
Resumen congreso2022 Diagnostic accuracy of MRE for staging hepatic fibrosis in patients with NAFLD JOURNAL OF HEPATOLOGY
Artículo2022 Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis GUT
Revisión2022 Dietary recommendations for the management of Non-alcoholic Fatty Liver Disease (NAFLD): a nutritional geometry perspective SEMINARS IN LIVER DISEASE
Resumen congreso2022 DIFFERENTIAL BIOMARKERS EXPRESSION IN THE TUMOR MICROENVIRONMENT OF RESECTED HEPATOCELLULAR CARCINOMA HEPATOLOGY
Resumen congreso2022 Dysregulation of the urea cycle enzymes determines a more severe NAFLD phenotype in a DIAMOND preclinical model JOURNAL OF HEPATOLOGY
Artículo2022 Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2022 EASL Clinical Practice Guidelines on the management of hepatic encephalopathy JOURNAL OF HEPATOLOGY
Revisión2022 Emerging pharmacological treatment options for MAFLD Therapeutic Advances in Endocrinology and Metabolism
Resumen congreso2022 EpCAM+CD133+Microvesicles: novel biomarker in NAFLD HEPATOLOGY
Revisión2022 Esteatohepatitis no alcohólica MEDICINA CLINICA
Artículo2022 Extracellular Vesicles as Biomarkers in Liver Disease INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Letter2022 Global multi-stakeholder endorsement of the MAFLD definition LANCET GASTROENTEROLOGY & HEPATOLOGY
Resumen congreso2022 Glutaminolysis and steatosis to steatohepatitis transition: role of glutaminase HEPATOLOGY
Artículo2022 Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies. Journal of Clinical and Translational Hepatology
Artículo2022 Hepatic encephalopathy Nature Reviews Disease Primers
Artículo2022 Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception FRONTIERS IN MOLECULAR BIOSCIENCES
Resumen congreso2022 Identification of new potential biomarkers to follow steatohepatitis in patients with non-alcoholic/metabolic-associated fatty liver disease JOURNAL OF HEPATOLOGY
Artículo2022 Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Resumen congreso2022 Impact of genes related to metabolic associated fatty liver disease (MAFLD) in response to hypocaloric dietary intervention: nutrigenomic analysis HEPATOLOGY
Resumen congreso2022 In cirrhotic patients with portal hypertension related bleeding. (B/PHT), the use of tamponade not followed by tips is an independent predictor of long-term (6-month and 1-year) mortality HEPATOLOGY
Artículo2022 Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance JHEP Reports
Artículo2022 Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function JOURNAL OF HEPATOLOGY
Artículo2022 Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation Scientific reports
Artículo2022 Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2022 Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma LIVER INTERNATIONAL
Artículo2022 Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles HEPATOLOGY
Artículo2022 Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events JOURNAL OF HEPATOLOGY
Artículo2022 Novel genes and sex differences in COVID-19 severity. HUMAN MOLECULAR GENETICS
Artículo2022 Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis JOURNAL OF HEPATOLOGY
Artículo2022 Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology LIVER INTERNATIONAL
Artículo2022 Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study NUTRICION HOSPITALARIA
Resumen congreso2022 Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice HEPATOLOGY
Resumen congreso2022 Rescue tips (Rtips) must be considered as soon as a tamponade is used: results from two international multicenter cohorts of 3019 patients with portal hypertension (PTH)-related bleeding. HEPATOLOGY
Artículo2022 Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: data from the global liver registry JOURNAL OF VIRAL HEPATITIS
Artículo2022 Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD Journal of Gastroenterology
Artículo2022 The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge? JOURNAL OF HEPATOLOGY
Artículo2022 Vitality, mental health and role-physical mediate the influence of coping on depressive symptoms and self-efficacy in patients with non-alcoholic fatty liver disease: a cross-sectional study JOURNAL OF PSYCHOSOMATIC RESEARCH
Resumen congreso2021 A global survey of physicians knowledge about non-alcoholic fatty liver disease (NAFLD) GASTROENTEROLOGY
Artículo2021 A machine learning approach enables quantitative measurement of liver histology and disease monitoring in NASH HEPATOLOGY
Artículo2021 A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C JOURNAL OF VIRAL HEPATITIS
Artículo2021 A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis NEW ENGLAND JOURNAL OF MEDICINE
Artículo2021 A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH NEW ENGLAND JOURNAL OF MEDICINE
Artículo2021 ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis HEPATOLOGY
Artículo2021 acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study EClinicalMedicine
Artículo2021 Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. JOURNAL OF CLINICAL INVESTIGATION
Artículo2021 An experimental DUAL model of advanced liver damage HEPATOLOGY COMMUNICATIONS
Revisión2021 Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases FRONTIERS IN IMMUNOLOGY
Artículo2021 Assessing the impact of COVID-19 on liver cancer management (CERO-19) JHEP Reports
Artículo2021 Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis. JOURNAL OF HEPATOLOGY
Resumen congreso2021 Circulating PCSK9 levels are correlated with advanced disease in patients with biopsy-proven non-alcoholic fatty liver disease. ATHEROSCLEROSIS
Artículo2021 Circulating tumor cells enumeration from the portal vein for risk stratification in early pancreatic cancer patients CANCERS
Artículo2021 Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States MEDICINE
Artículo2021 Clinical characteristics and outcome of drug-induced liver injury in the older patients: from the young-old to the oldest-old CLINICAL PHARMACOLOGY & THERAPEUTICS
Resumen congreso2021 CLINICAL PRESENTATION AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS: DATA FROM THE GLOBAL LIVER REGISTRY (TM) GASTROENTEROLOGY
Resumen congreso2021 Clinical presentation of lean non-alcoholic fatty liver disease (NAFLD) across the world: data from the global nash registry GASTROENTEROLOGY
Artículo2021 CO-11. Monitorización de la adherencia a la dieta sin gluten mediante la determinación de péptidos inmunogénicos del gluten (gip) en orina: Concordancia con la lesión mucosa duodenal en los pacientes con enfermedad celiaca Revista Andaluza de Patología Digestiva
Artículo2021 CO-14. Evaluación de la capacidad diagnóstica de fibrosis y cuantificación de esteatosis hepática mediante rm en pacientes con esteatosis hepática metabólica (ehmet) Revista Andaluza de Patología Digestiva
Artículo2021 Coexpression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease. JOURNAL OF HEPATOLOGY
Artículo2021 Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- And long-term prediction of hepatocellular carcinoma among cirrhotic patients WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2021 Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry JOURNAL OF HEPATOLOGY
Artículo2021 Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease EBIOMEDICINE
Letter2021 COVID-19 and the liver: the chicken or the egg dilemma Revista Española de Enfermedades Digestivas
Revisión2021 Defining comprehensive models of care for NAFLD Nature Reviews Gastroenterology and Hepatology
Artículo2021 Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: a longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects LIVER INTERNATIONAL
Artículo2021 Development and validation of a clinical-genetic risk score to predict hepatic encephalopathy in patients with liver cirrhosis. AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2021 Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis JOURNAL OF HEPATOLOGY
Artículo2021 Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis LIVER INTERNATIONAL
Editorial2021 EASL international recognition award recipient 2021: Prof. Dr. Nahum Méndez-Sánchez JOURNAL OF HEPATOLOGY
Artículo2021 Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data GASTROENTEROLOGY
Artículo2021 European 'NAFLD Preparedness Index' - Is Europe ready to meet the challenge of fatty liver disease? JHEP Reports
Artículo2021 Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis Scientific reports
Revisión2021 Gut-liver axis in nonalcoholic fatty liver disease: the impact of the metagenome, end products, and the epithelial and vascular barriers SEMINARS IN LIVER DISEASE
Resumen congreso2021 Impact of a loss-of-function variant in HSD17B13 on hepatic decompensation and mortality in cirrhotic patients JOURNAL OF HEPATOLOGY
Artículo2021 Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World journal of virology
Artículo2021 Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis Revista Española de Enfermedades Digestivas
Artículo2021 Impacto clínico y económico global de la enfermedad hepática por hígado graso no alcohólico Revista Española de Enfermedades Digestivas
Artículo2021 Implementing personalized medicine in COVID-19 in Andalusia: an opportunity to transform the healthcare system. Journal of personalized medicine
Artículo2021 Influence of psychological biomarkers on therapeutic adherence by patients with non-alcoholic fatty liver disease: a moderated mediation model JOURNAL OF CLINICAL MEDICINE
Artículo2021 Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review Scientific reports
Artículo2021 Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease. JOURNAL OF HEPATOLOGY
Resumen congreso2021 LOW HYPOCALORIC MEDITERRANEAN DIET VERSUS STANDARD DIET IN BIOPSY PROVEN NAFLD PATIENTS HEPATOLOGY
Artículo2021 Management of NAFLD patients with advanced fibrosis LIVER INTERNATIONAL
Artículo2021 Mapping the human genetic architecture of COVID-19. NATURE
Artículo2021 Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the fibroblast growth factor 21 locus ADVANCED SCIENCE
Artículo2021 Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Artículo2021 Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2021 PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis JOURNAL OF HEPATOLOGY
Editorial2021 Propuesta de nueva denominación: esteatosis hepática metabólica (EHmet) Revista Española de Enfermedades Digestivas
Artículo2021 Quality of life and coping in nonalcoholic fatty liver disease: influence of diabetes and obesity INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
Letter2021 Reply to: “The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD” JOURNAL OF HEPATOLOGY
Artículo2021 Simple non-invasive scoring systems and histologic scores in predicting mortality in NAFLD patients: a systematic review and meta-analysis JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Letter2021 Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation Clinical and translational medicine
Artículo2021 The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma EBIOMEDICINE
Artículo2021 Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Artículo2021 Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility PLOS ONE
Revisión2021 Wilson's disease: revisiting an old friend World Journal of Hepatology
Artículo2020 A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe JOURNAL OF HEPATOLOGY
Resumen congreso2020 A global review of national NAFLD and NASH policies HEPATOLOGY
Revisión2020 A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement JOURNAL OF HEPATOLOGY
Resumen congreso2020 A retrospective registry review of chronic viral hepatitis patients and associated risk factors of late presentation to care in Spain, a country with unrestricted treatment access HEPATOLOGY
Resumen congreso2020 A systematic review of comprehensive models of care for NAFLD and NASH HEPATOLOGY
Artículo2020 Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients LIVER INTERNATIONAL
Resumen congreso2020 Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis (NASH) HEPATOLOGY
Resumen congreso2020 Clinical and patient-reported outcomes data of non-alcoholic fatty liver disease: longitudinal data from the global NASH registry (TM) HEPATOLOGY
Artículo2020 Co-17. Determinación de micropartículas apoptóticas de origen hepático en pacientes con enfermedad hepática metabólica grasa Revista Andaluza de Patología Digestiva
Resumen congreso2020 Coping strategies predicting quality of life in diabetic and obese NAFLD patients EUROPEAN JOURNAL OF PUBLIC HEALTH
Artículo2020 Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study JHEP Reports
Artículo2020 Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure ANTIVIRAL RESEARCH
Artículo2020 Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Artículo2020 Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain MEDICINE
Corrección2020 Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH JOURNAL OF HEPATOLOGY
Artículo2020 Fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis: the impact on patient-reported outcomes HEPATOLOGY COMMUNICATIONS
Resumen congreso2020 FIB-4 and fibroscan can identify patients with nonalcoholic fatty liver disease who are at risk of liver-related events: results of a longitudinal analysis with comparison with liver biopsy HEPATOLOGY
Editorial2020 Foreword NAFLD and NASH: biomarkers in detection, diagnosis and monitoring
Artículo2020 Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease PLOS ONE
Artículo2020 Genomewide association study of severe covid-19 with respiratory failure NEW ENGLAND JOURNAL OF MEDICINE
Artículo2020 Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study Clinical and translational gastroenterology
Resumen congreso2020 High prevalence of fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH): the impact on patient-reported outcomes (PROs) DIABETES
Revisión2020 Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice Journal of gastrointestinal and liver diseases : JGLD
Artículo2020 Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus AMERICAN JOURNAL OF GASTROENTEROLOGY
Resumen congreso2020 Liver stiffness measurement by fibroscan predicts the occurrence of liver-related events and death in patients with NAFLD-related compensated advanced chronic liver disease DIGESTIVE AND LIVER DISEASE
Artículo2020 MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease GASTROENTEROLOGY
Artículo2020 Management of chronic liver disease-associated severe thrombocytopenia in Spain: A view from the experts Revista Española de Enfermedades Digestivas
Capítulo2020 Morbid obesity and hepatitis C: treat as normal or are there additional issues to consider? Clinical Dilemmas in Viral Liver Disease, Second Edition
Libro2020 NAFLD and NASH: Biomarkers in detection, diagnosis and monitoring NAFLD and NASH: biomarkers in detection, diagnosis and monitoring
Artículo2020 Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: new proposals for follow-up in celiac disease AMERICAN JOURNAL OF CLINICAL NUTRITION
Artículo2020 Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice Polish archives of internal medicine
Resumen congreso2020 Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study DIGESTIVE AND LIVER DISEASE
Resumen congreso2020 Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 regenerate study DIGESTIVE AND LIVER DISEASE
Artículo2020 Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy LIVER INTERNATIONAL
Resumen congreso2020 Patient-reported outcomes in patients with chronic hepatitis C: data from the global liver registry (TM) HEPATOLOGY
Artículo2020 Programa poblacional de cribado de cáncer colorrectal. Documento de posicionamiento de la Sociedad Andaluza de Patología Digestiva. Requisitos mínimos para un cribado de calidad. Revista Andaluza de Patología Digestiva
Artículo2020 Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease FRONTIERS IN MEDICINE
Artículo2020 qFIBS: an automated technique for quantitative evaluation of fibrosis, inflammation, ballooning, and steatosis in patients with nonalcoholic steatohepatitis HEPATOLOGY
Artículo2020 Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS JOURNAL OF HEPATOLOGY
Editorial2020 Redefining non-alcoholic fatty liver disease: what's in a name? LANCET GASTROENTEROLOGY & HEPATOLOGY
Resumen congreso2020 Selection based on SAF activity score, not NASH CRN NAFLD activity score, leads to selection of a patient cohort with more severe NASH with more advanced fibrosis: experience from the native phase 2b study of the panppar agonist lanifibranor HEPATOLOGY
Artículo2020 Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials JOURNAL OF HEPATOLOGY
Artículo2020 Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH JOURNAL OF HEPATOLOGY
Resumen congreso2020 Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians HEPATOLOGY
Artículo2020 Stratification of patients in NASH clinical trials: a pitfall for trial success JHEP Reports
Artículo2020 Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly CELL METABOLISM
Resumen congreso2020 The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries DIGESTIVE AND LIVER DISEASE
Resumen congreso2020 The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries DIGESTIVE AND LIVER DISEASE
Resumen congreso2020 The enhanced liver fibrosis (ELF) score predicts adverse clinical and patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH) DIABETES
Resumen congreso2020 The European NAFLD policy index - how well are countries prepared? HEPATOLOGY
Artículo2020 The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease Contemporary Clinical Trials
Resumen congreso2020 The impact of chronic hepatitis B on patient-reported outcomes from the global liver registry (TM) HEPATOLOGY
Resumen congreso2020 The impact of fatigue on patient-reported outcomes (PRO) in patients with chronic liver disease (CLD): data from the global liver registry (GLR) GASTROENTEROLOGY
Resumen congreso2020 The panppar agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the native phase 2b trial HEPATOLOGY
Artículo2020 The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology JOURNAL OF HEPATOLOGY
Revisión2020 The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management LIVER INTERNATIONAL
Resumen congreso2020 The serum-based metabolomics advanced steatohepatits fibrosis score (MASEF) for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant fibrosis HEPATOLOGY
Resumen congreso2020 Validation of a machine learning-based approach (delta liver fibrosis score) for the assessment of histologic response in patients with advanced fibrosis due to NASH HEPATOLOGY
Editorial2020 What has the COVID-19 pandemic taught us so far? Addressing the problem from a hepatologist’s perspective Journal of Clinical and Translational Hepatology
Artículo2019 A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy OBESITY SURGERY
Artículo2019 A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3 ' UTR JOURNAL OF HEPATOLOGY
Artículo2019 A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-beta 1 dependent mechanisms Scientific reports
Resumen congreso2019 ACUTE ON CHRONIC LIVER FAILURE IS A MAJOR RISK FACTOR FOR BLEEDING CONTROL AND MORTALITY, WHILE PRE-EMPTIVE TIPS IMPROVES SURVIVAL IN THESE PATIENTS HEPATOLOGY
Resumen congreso2019 ALGORITHMS USING NONINVASIVE TESTS CAN ACCURATELY IDENTIFY PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH: DATA FROM THE STELLAR CLINICAL TRIALS GUT
Resumen congreso2019 Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trials DIGESTIVE AND LIVER DISEASE
Artículo2019 Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria Revista Española de Enfermedades Digestivas
Resumen congreso2019 Baseline characteristics of patients with and without diabetes in trials for advanced fibrosis/cirrhosis due to nonalcoholic steatohepatitis (NASH) DIABETOLOGIA
Artículo2019 Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization FASEB JOURNAL
Resumen congreso2019 CLINICAL AND PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY HEPATOLOGY
Resumen congreso2019 CLINICAL AND PATIENT-REPORTED OUTCOMES DATA FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY HEPATOLOGY
Artículo2019 Co-03. La ldl oxidada es un biomarcador distintivo de la presencia de esteatohepatitis frente a fibrosis hepática en enfermedad hepática metabólica grasa Revista Andaluza de Patología Digestiva
Artículo2019 Co-12. Impacto de la fibrosis sobre la salud mental de pacientes con enfermedad hepática grasa no alcohólica (ehgna) Revista Andaluza de Patología Digestiva
Resumen congreso2019 CURRENTLY AVAILABLE NONINVASIVE TESTS ACCURATELY STAGE FIBROSIS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) HEPATOLOGY
Resumen congreso2019 DESCRIPTION OF VIRAL HEPATITIS PATIENTS AND ASSOCIATED RISK FACTORS OF LATE PRESENTATION TO CARE IN SPAIN: A COUNTRY WITH UNRESTRICTED ACCESS TO TREATMENT HEPATOLOGY
Resumen congreso2019 DETERMINING THE EPIDEMIOLOGY, PATIENT FLOW, TREATMENT AND UNMET NEEDS OF PATIENTS WITH CHRONIC LIVER DISEASE-ASSOCIATED SEVERE THROMBOCYTOPENIA UNDERGOING INVASIVE PROCEDURES IN SPAIN VALUE IN HEALTH
Resumen congreso2019 DIFFERENCES IN THE CLINICAL PROFILE OF THE MOST COMMON CAUSES OF CHRONIC LIVER DISEASE (CLD) ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY. HEPATOLOGY
Artículo2019 Does the Antitumor Necrosis Factor-alpha Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease? JOURNAL OF CLINICAL DENSITOMETRY
Resumen congreso2019 Droplet digital pcr analysis of circulating lncrna h19: a potential biomarker for hepatocellular carcinoma HEPATOLOGY
Artículo2019 Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort JOURNAL OF VIRAL HEPATITIS
Artículo2019 Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2019 Effects of fatty acids and polyphenols from extra virgin olive oil in a murine animal dietary model knockout for the LDL receptor JOURNAL OF HEPATOLOGY
Resumen congreso2019 Effects of sustained virological response on the endothelial dysfunction and the cardiovascular risk in hepatitis C after direct antiviral angets treatment: HEPCAR study JOURNAL OF HEPATOLOGY
Artículo2019 Eliminación de la hepatitis C. Documento de posicionamiento de la Asociación Española para el Estudio del Hígado (AEEH) GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2019 Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH) Revista Española de Enfermedades Digestivas
Artículo2019 Enfermedad hepática por alcohol. Guías de práctica clínica. Documento de consenso auspiciado por la AEEH GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2019 Epigenetic regulation of gene expression in a HCC-NASH murine model JOURNAL OF HEPATOLOGY
Resumen congreso2019 FACTORS PREDICTING SURVIVAL IN PATIENTS WITH 'NON-HIGH-RISK' ACUTE VARICEAL BLEEDING RECEIVING NSBB AND/OR EBL TO PREVENT RE-BLEEDING HEPATOLOGY
Resumen congreso2019 Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS JOURNAL OF HEPATOLOGY
Resumen congreso2019 Genetic Fingerprint of Hepatic Encephalopathy Risk in Liver Cirrhosis AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2019 Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Editorial2019 Hepatic encephalopathy and traffic accidents: Vigilance is needed! JOURNAL OF HEPATOLOGY
Resumen congreso2019 HETEROGENEITY OF CIRCULATING TUMOR CELLS BASED ON ASIALOGLYCOPROTEIN RECEPTOR 1 (ASGPR1) EXPRESSION IN HEPATOCELLULAR CARCINOMA AS PROGNOSTIC TOOL HEPATOLOGY
Artículo2019 Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD) Revista Española de Enfermedades Digestivas
Resumen congreso2019 IDENTIFICATION OF SERUM METABOLITES AS DIAGNOSTIC BIOMARKERS FOR ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH) HEPATOLOGY
Resumen congreso2019 Impact of age on routinely available non-invasive tests for the discrimination of advanced fibrosis due to NASH in the phase 3 STELLAR trials of the ASK1 inhibitor selonsertib JOURNAL OF HEPATOLOGY
Resumen congreso2019 INTRATUMORAL EXPRESSION OF PD-1/PD-L1 IMMUNE CHECKPOINT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA HEPATOLOGY
Artículo2019 Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models Revista Española de Enfermedades Digestivas
Artículo2019 Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2019 NONINVASIVE TESTS (NITS) MORE ACCURATELY CAPTURE SURROGATES OF CLINICAL RESPONSE THAN LIVER HISTOLOGY IN NASH PATIENTS WITH ADVANCED FIBROSIS HEPATOLOGY
Artículo2019 Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials HEPATOLOGY
Resumen congreso2019 OBESE PATIENTS CARRYING NAFLD-ASSOCIATED GENETIC VARIANTS PRESENT SPECIFIC SERUM AND LIVER LIPIDOMIC PROFILES: IDENTIFICATION OF A LIPIDOMIC SIGNATURE IN SERUM TO ESTIMATE THE LIVER FAT CONTENT HEPATOLOGY
Resumen congreso2019 OBETICHOLIC ACID (OCA) IMPROVES NON-INVASIVE MARKERS OF FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH): A SECONDARY ANALYSIS OF THE PHASE 3 REGENERATE STUDY HEPATOLOGY
Artículo2019 Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial LANCET
Resumen congreso2019 OPTIMAL TIMING OF ENDOSCOPY IS ASSOCIATED WITH LOWER 42-DAY MORTALITY IN VARICEAL BLEEDING GASTROINTESTINAL ENDOSCOPY
Resumen congreso2019 Optimal timing of endoscopy is associated with lower 42-day mortality in variceal bleeding JOURNAL OF HEPATOLOGY
Resumen congreso2019 Overlap of primary biliary cholangitis and autoimmune hepatitis. Natural history and prognosis in a large cohort of patients from Spain JOURNAL OF HEPATOLOGY
Resumen congreso2019 Oxidized LDL is a distinctive biomarker of NASH independently of liver fibrosis in patients with NAFLD JOURNAL OF HEPATOLOGY
Resumen congreso2019 OXIDIZED-LDL AS A MARKER OF OXIDATIVE STRESS IS STRONGLY RELATED TO NASH IRRESPECTIVELY OF INSULIN RESISTANCE AND LIVER FIBROSIS HEPATOLOGY
Resumen congreso2019 PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPENSATED CIRRHOSIS (CC): DATA FROM THE STELLAR-4 PHASE 3 CLINICAL TRIAL HEPATOLOGY
Artículo2019 Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study HEPATOLOGY
Otros2019 Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2019 RACE DOES NOT AFFECT THE PERFORMANCE OF ROUTINELY AVAILABLE NONINVASIVE TESTS FOR THE DISCRIMINATION OF ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE PHASE 3 STELLAR TRIALS OF SELONSERTIB HEPATOLOGY
Revisión2019 Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis TRANSPLANTATION
Artículo2019 Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Artículo2019 Relationship between self-perceived health, vitality, and posttraumatic growth in liver transplant recipients FRONTIERS IN PSYCHOLOGY
Artículo2019 Requisitos para la sedación en Unidades de Endoscopia Digestiva. Recomendaciones de la Sociedad Andaluza de Patología Digestiva. Revista Andaluza de Patología Digestiva
Resumen congreso2019 Respiratory infection in patients with cirrhosis and acute variceal bleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patients JOURNAL OF HEPATOLOGY
Resumen congreso2019 Rising economic burden following the diagnosis of compensated cirrhosis among hospitalized patients with Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in Spain JOURNAL OF HEPATOLOGY
Resumen congreso2019 ROUTINELY AVAILABLE NONINVASIVE TESTS DISCRIMINATE ADVANCED FIBROSIS DUE TO NASH IN THE PHASE 3 STELLAR TRIALS OF THE ASK1 INHIBITOR SELONSERTIB GUT
Resumen congreso2019 SAFETY AND EFFICACY OF SELONSERTIB FOR THE TREATMENT OF BRIDGING FIBROSIS OR COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH): RESULTS OF THE PHASE 3 STELLAR STUDIES HEPATOLOGY
Artículo2019 Sesión IV.: Búsqueda de biomarcadores en la enfermedad hepática metabólica grasa: aproximación transcriptómica Revista Andaluza de Patología Digestiva
Resumen congreso2019 SEVERE IMPAIRMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY HEPATOLOGY
Resumen congreso2019 THE BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE EU5 COUNTRIES VALUE IN HEALTH
Resumen congreso2019 The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD JOURNAL OF HEPATOLOGY
Resumen congreso2019 THE ECONOMIC COST AND HEALTH BURDEN OF NON ALCOHOLIC STEATOHEPATITIS IN THE EU5 COUNTRIES HEPATOLOGY
Resumen congreso2019 The presence of type 2 diabetes is independently associated with impairment of patient- reported outcomes in patients with non-alcoholic steatohepatitis JOURNAL OF HEPATOLOGY
Resumen congreso2019 The socio-economic burden of NASH in Europe and the United States: The gain study JOURNAL OF HEPATOLOGY
Resumen congreso2019 Transcriptomic and epigenetic characterization of a NAFLD murine model JOURNAL OF HEPATOLOGY
Resumen congreso2019 UREA CYCLE ENZYMES DYSREGULATION IS LINKED TO A MORE AGGRESSIVE NAFLD PHENOTYPE. HEPATOLOGY
Revisión2019 Use of Steatotic Grafts in Liver Transplantation: Current Status LIVER TRANSPLANTATION
Artículo2019 Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites Revista Española de Enfermedades Digestivas
Resumen congreso2019 VALIDATION OF HISTOLOGIC AND NONINVASIVE MEASURES OF FIBROSIS AS SURROGATE ENDPOINTS OF DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) HEPATOLOGY
Resumen congreso2019 VISCOELASTICITY AND STIFFNESS RESPONSE (VSR) WAS MODULATED BY ADIPOKINES HOMEOSTASIS BEYOND OF HCV CLEARANCE. HEPATOLOGY
Artículo2019 Water-soluble extracts from edible mushrooms (Agaricus bisporus) as inhibitors of hepatitis C viral replication FOOD & FUNCTION
Resumen congreso2019 What are the predictors of impairment of patient-reported outcome in non-alcoholic steatohepatitis? JOURNAL OF HEPATOLOGY
Resumen congreso2018 A novel predictive model of liver decompensation in patients with non-alcoholic fatty liver related cirrhosis JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2018 Abide: A Novel Predictive Model of Liver Decompensation in Patients with Non-Alcoholic Fatty Liver Related Cirrhosis. HEPATOLOGY
Resumen congreso2018 Advanced Fibrosis Based on Noninvasive Tests in Nonalcoholic Steatohepatitis (NASH) Is Associated with Impairment of Patient-Reported Outcomes HEPATOLOGY
Resumen congreso2018 Algorithms Using Noninvasive Tests Can Accurately Identify Patients with Advanced Fibrosis Due to Nash: Data from the Stellar Clinical Trials HEPATOLOGY
Resumen congreso2018 Burden and Variability in the Management of NAFLD Patients in Clinical Practice: Toward Unified Criteria. HEPATOLOGY
Resumen congreso2018 Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry JOURNAL OF HEPATOLOGY
Resumen congreso2018 Co-20. Mejora de la función endotelial en pacientes con virus c tras el tratamiento con aad Revista Andaluza de Patología Digestiva
Artículo2018 Co-21. Uso de microarns como biomarcadores no invasivos en enfermedad hepática metabólica por depósito de grasa no alcohólica Revista Andaluza de Patología Digestiva
Artículo2018 Co-28. Carga y variabilidad en el manejo de pacientes con ehgna en la práctica clínica: Hacia criterios unificados Revista Andaluza de Patología Digestiva
Artículo2018 Co-29. Investigación traslacional en ehgna: Estudio genético y funcional de fgf-21 Revista Andaluza de Patología Digestiva
Artículo2018 Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2018 Critical flicker frequency improves its diagnostic and predictive accuracy of hepatic encephalopathy by decreasing the dispersion between measures JOURNAL OF HEPATOLOGY
Resumen congreso2018 Diabetes but Not Metabolic Syndrome Adversely Impact Survival or Liver Decompensation in Patients with Non-Alcoholic Fatty Liver Related Cirrhosis. HEPATOLOGY
Artículo2018 Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis LIVER INTERNATIONAL
Resumen congreso2018 DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome JOURNAL OF HEPATOLOGY
Artículo2018 Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients Therapeutic Advances in Gastroenterology
Resumen congreso2018 Dynamic of Microparticles in Patients with Hepatitis C Receiving Daa and Their Impact on Cardiovascular Risk: Hepcar Study HEPATOLOGY
Editorial2018 Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Resumen congreso2018 Effect of hepatitis C sustained virological response on the endothelial dysfunction and the cardiovascular risk. HepCAR study JOURNAL OF HEPATOLOGY
Resumen congreso2018 EUS-GUIDED INTERVENTIONS ON THE VASCULAR SYSTEM: AN ACADEMIC SINGLE-CENTER EXPERIENCE GASTROINTESTINAL ENDOSCOPY
Resumen congreso2018 Extrahepatic Autoimmune Comorbidities in Patients with Primary Biliary Cholangitis. Lack of Association with Prognosis and Therapeutic Response to Ursodeoxycholic Acid. HEPATOLOGY
Corrección2018 Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349] Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349] GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2018 Fibroblast Growth Factor 21 (FGF21) in NAFLD: From a Biomarker to a Therapeutic Target. HEPATOLOGY
Artículo2018 Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study GASTROENTEROLOGY
Resumen congreso2018 Genetic and functional analysis of FGF21 in NAFLD/NASH JOURNAL OF HEPATOLOGY
Resumen congreso2018 Genetic factors of hepatic encephalopathy on patients with cirrhosis: candidate gene study JOURNAL OF HEPATOLOGY
Resumen congreso2018 Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice JOURNAL OF HEPATOLOGY
Artículo2018 Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Artículo2018 Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Otros2018 High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Artículo2018 Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C JOURNAL OF HEPATOLOGY
Resumen congreso2018 Metabolically Healthy Obesity Is a Dynamic Condition Which Progress to Unhealthy Status According to Nash and Fibrosis Stage in Biopsy-Proven NAFLD Patients HEPATOLOGY
Resumen congreso2018 Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity JOURNAL OF HEPATOLOGY
Artículo2018 Metabolomic-Based Noninvasive Serum Test to Diagnose Nonalcoholic Steatohepatitis: Results From Discovery and Validation Cohorts HEPATOLOGY COMMUNICATIONS
Artículo2018 Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy Revista Española de Enfermedades Digestivas
Artículo2018 Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Revisión2018 miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis JOURNAL OF HEPATOLOGY
Artículo2018 Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 JOURNAL OF HEPATOLOGY
Artículo2018 Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2018 Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype ANNALS OF HEPATOLOGY
Resumen congreso2018 New Automated Evaluation Tool Qfibs - Quantitative Assessment for Fibrosis, Inflammation, Ballooning, and Steatosis in Patients with Non-Alcoholic Steatohepatitis HEPATOLOGY
Resumen congreso2018 Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcoholic Fatty Liver Disease (AFLD): The Impact of Alcohol Consumption and Metabolic Syndrome on Mortality HEPATOLOGY
Resumen congreso2018 Non-alcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma listed for liver transplantation in United States: data from the Scientific Registry of Transplant Recipients TRANSPLANTATION
Revisión2018 Nuevas perspectivas terapéuticas en la esteatohepatitis no alcohólica GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2018 Peer-to-Peer Sessions in Primary Care to Improve the Hepatitis B Detection Rate in Seville, Spain ANNALS OF HEPATOLOGY
Resumen congreso2018 Pregnancy and autoimmune hepatitis: presentation and outcomes JOURNAL OF HEPATOLOGY
Resumen congreso2018 Primary biliary cholangitis in Spain: fewer symptoms and milder disease at presentation, but similar therapeutic response over the years JOURNAL OF HEPATOLOGY
Artículo2018 Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment Revista Española de Enfermedades Digestivas
Resumen congreso2018 Role of the Long Non-Coding RNA H19 in the Context of Hepatocellular Carcinoma HEPATOLOGY
Resumen congreso2018 Routinely Available Noninvasive Tests Discriminate Advanced Fibrosis Due to Nash in the Phase 3 Stellar Trials of the ASK1 Inhibitor Selonsertib HEPATOLOGY
Resumen congreso2018 Severe Impairment of Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Non-Alcoholic Steatohepatitis (NASH) HEPATOLOGY
Artículo2018 Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy PLOS ONE
Resumen congreso2018 Steatohepatitis and Fibrosis Influence the Occurrence of Type 2 Diabetes Mellitus during the Follow-up in Non-Diabetic Biopsy-Proven NAFLD Patients HEPATOLOGY
Artículo2018 The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Revisión2018 The impact of minimal hepatic encephalopathy treatment in long-term prognosis Salud(i)Ciencia
Resumen congreso2017 A pragmatic algorithm to rule out Non-alcoholic steatohepatitis in patients at risk of non-alcoholic fatty liver disease in spite of a normal ultrasound JOURNAL OF HEPATOLOGY
Artículo2017 A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naive and previously treated patients Revista Española de Enfermedades Digestivas
Artículo2017 Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2017 An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice MOLECULAR NUTRITION & FOOD RESEARCH
Revisión2017 Cardiovascular assessment in liver transplant for nonalcoholic steatohepatitis patients: What we do, what we should do World Journal of Hepatology
Resumen congreso2017 Clinical characteristics and outcomes of elderly included in the Spanish Drug-Induced Liver Injury (DILI) Registry JOURNAL OF HEPATOLOGY
Artículo2017 Co-11. La frecuencia crítica de parpadeo mejora su rendimiento diagnóstico y predictivo de encefalopatía hepática al incorporar la desviación estándar como criterio de calidad Revista Andaluza de Patología Digestiva
Artículo2017 Co-12. Papel del factor de crecimiento de fibroblasto 21 (fgf21) en pacientes con eghna: Estudio genético y funcional Revista Andaluza de Patología Digestiva
Artículo2017 Co-19. Estudio del perfil epigenético en una cohorte de pacientes con hepatitis crónica c: Cirróticos versus hepatocarcinoma Revista Andaluza de Patología Digestiva
Artículo2017 Co-20. Validación de los índices fib 4 y nfs para discriminar fibrosis hepática en pacientes con eghna en práctica clínica habitual. Revista Andaluza de Patología Digestiva
Artículo2017 Co-26. Efectos secundarios e influencia sobre la rigidez hepática del metotrexate en pacientes con enfermedad de crohn Revista Andaluza de Patología Digestiva
Artículo2017 Co-28. The impact of age on phenotypic presentation and severity in patients with idiosyncratic drug-induced liver injury (dili) Revista Andaluza de Patología Digestiva
Resumen congreso2017 Comprehensive NAFLD diagnosis based on a noninvasive metabolomic approach in a liquid biopsy JOURNAL OF HEPATOLOGY
Editorial2017 Detecting liver fat from viscoelasticity: How good is CAP in clinical practice? The need for universal cut-offs JOURNAL OF HEPATOLOGY
Artículo2017 Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months DIGESTIVE DISEASES AND SCIENCES
Corrección2017 Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months DIGESTIVE DISEASES AND SCIENCES
Resumen congreso2017 Effectiveness And Safety Of Elbasvir/Grazoprevir Treatment For HCV Patients In Real-Life Clinical Practice: Results From Spanish Hepa-C Cohort HEPATOLOGY
Artículo2017 Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System MEDICINA CLINICA
Artículo2017 Endoscopic ultrasound-guided placement of plastic pigtail stents for the drainage of refractory malignant ascites Endoscopy International Open
Artículo2017 Evolution of the incidence of inflammatory bowel disease in Southern Spain Revista Española de Enfermedades Digestivas
Corrección2017 Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients (vol 111, pg 1456, 2016) AMERICAN JOURNAL OF GASTROENTEROLOGY
Resumen congreso2017 Genetic determinants influencing on overt hepatic encephalopathy and acute-on-chronic liver failure JOURNAL OF HEPATOLOGY
Editorial2017 Hepatitis B and NAFLD: Lives Crossed ANNALS OF HEPATOLOGY
Resumen congreso2017 HepCom: impact of co-morbidities on the final success of direct antiviral agents therapy in hepatitis C JOURNAL OF HEPATOLOGY
Resumen congreso2017 High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry JOURNAL OF HEPATOLOGY
Artículo2017 High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4 LIVER INTERNATIONAL
Resumen congreso2017 Idiosyncratic Drug-Induced Liver Injury: A 20-Year Update of the Cases Enrolled by the Spanish dili Registry DRUG SAFETY
Artículo2017 IFN-lambda 3, not IFN-lambda 4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis NATURE GENETICS
Artículo2017 Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2017 Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy LIVER INTERNATIONAL
Artículo2017 Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Resumen congreso2017 Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLD JOURNAL OF HEPATOLOGY
Artículo2017 Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis GASTROENTEROLOGY
Resumen congreso2017 Modulation of the fecal metagenome in patients with Crohn's disease JOURNAL OF CROHNS & COLITIS
Resumen congreso2017 Oral glutamine challenge predicts risk and defines hepatic encephalopathy types JOURNAL OF HEPATOLOGY
Resumen congreso2017 PROSPECTIVE DRUG-INDUCED LIVER INJURY REGISTRY: CLINICAL CHARACTERISTICS AND OUTCOMES OF 915 CASES BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Artículo2017 Simeprevir in combination with sofosbuvir in treatment-naive and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO) ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2017 Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Resumen congreso2017 The impact of age on phenotype presentation and severity in patients with idiosyncratic drug-induced liver injury (DILI) HEPATOLOGY
Resumen congreso2017 The Long-Term Clinical Course of Histologically Advanced Nonalcoholic Fatty Liver Disease. Impact of Fibrosis Severity on Major Clinical Outcomes. HEPATOLOGY
Resumen congreso2017 Time in HE in cirrhotic patients with an acute episode (>= grade 2) determines short and long-term survival JOURNAL OF HEPATOLOGY
Letter2017 TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C GASTROENTEROLOGY
Artículo2017 Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry HEPATOLOGY
Revisión2017 Treatment of NAFLD with diet, physical activity and exercise JOURNAL OF HEPATOLOGY
Resumen congreso2017 Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study. HEPATOLOGY
Resumen congreso2016 A NON-INVASIVE LIPIDOMIC TEST ACCURATELY DISCRIMINATES NON-ALCOHOLIC STEATOHEPATITIS FROM STEATOSIS: A BLIND VALIDATION STUDY JOURNAL OF HEPATOLOGY
Resumen congreso2016 A POST-HOC ANALYSIS OF THE GOLDEN505 TRIAL DEMONSTRATES HISTOLOGICAL AND CARDIOMETABOLIC EFFICACY OF ELAFIBRANOR-120 MG IN PATIENTS WITH MODERATE OR SEVERE NASH THAT ARE ELIGIBLE FOR PHARMACOTHERAPY JOURNAL OF HEPATOLOGY
Artículo2016 A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2 alpha/Ribavirin PLOS ONE
Resumen congreso2016 Advanced fibrosis is independently associated with impaired kidney function in biopsy-proven NAFLD. Results of a multicenter cross-sectional study HEPATOLOGY
Artículo2016 Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting The MENTE Study JOURNAL OF CLINICAL GASTROENTEROLOGY
Revisión2016 Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis SEMINARS IN LIVER DISEASE
Resumen congreso2016 Charlson Comorbidity Index predicts the overall benefit of IFN-free therapy in hepatitis (HepCom Study) HEPATOLOGY
Artículo2016 Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods JOURNAL OF CLINICAL MICROBIOLOGY
Resumen congreso2016 Critical Flicker Frequency predicts progression among stages of cirrhosis HEPATOLOGY
Artículo2016 Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury JOURNAL OF HEPATOLOGY
Artículo2016 Development and Validation of a Noninvasive Prediction Model for Nonalcoholic Steatohepatitis Resolution After Lifestyle Intervention HEPATOLOGY
Resumen congreso2016 DEVELOPMENTAND VALIDATION OF A NON-INVASIVE MODEL FOR PREDICTING FIBROSIS RESOLUTION ONE YEAR AFTER LIFESTYLE INTERVENTION FOR BIOPSY-PROVEN NON-ALCOHOLIC STEATOHEPATITIS JOURNAL OF HEPATOLOGY
Artículo2016 Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2016 Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes HEPATOLOGY
Resumen congreso2016 Early-TIPS improves survival in high-risk variceal bleeders. Results of a Multicenter Variceal Bleeding Observational Study HEPATOLOGY
Artículo2016 Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets Scientific reports
Artículo2016 El ejercicio físico en la hepatitis crónica C: Revisión en la literatura Revista Andaluza de Patología Digestiva
Artículo2016 Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-alpha and -delta, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening GASTROENTEROLOGY
Resumen congreso2016 Eliminating Hepatitis C in Spain: Bridging from the National Health Plan HEPATOLOGY
Artículo2016 Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2016 FibroGENE: A gene-based model for staging liver fibrosis JOURNAL OF HEPATOLOGY
Resumen congreso2016 HCV GENOTYPE 3: META-ANALYSIS WITH AVAILABLE TREATMENT OPTIONS JOURNAL OF HEPATOLOGY
Artículo2016 Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options WORLD JOURNAL OF GASTROENTEROLOGY
Resumen congreso2016 HEPATOTOXICITY ASSOCIATED WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. A COMPARATIVE ANALYSIS AMONG IBUPROFEN, DICLOFENAC AND NIMESULIDE FROM THE SPANISH AND LATIN-AMERICAN DILI REGISTRIES JOURNAL OF HEPATOLOGY
Resumen congreso2016 HIGH RESOLUTION ANALYSIS FOR GENOTYPES AND SUB-GENOTYPES IDENTIFICATION IN HEPATITIS C REVEALS THE IMPORTANCE OF MIXED INFECTIONS FOR OPTIMAL THERAPY JOURNAL OF HEPATOLOGY
Letter2016 Identifying Patients With Nonalcoholic Steatohepatitis That Are Nonresponders to Therapy Reply HEPATOLOGY
Artículo2016 Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease Scientific reports
Resumen congreso2016 IMPACT OF BASAL COMORBIDITIES ON THE OVERALL BENEFIT OF DAA THERAPY IN HEPATITIS C JOURNAL OF HEPATOLOGY
Resumen congreso2016 IMPACT OF GWAS-IDENTIFIED COMMON VARIANTS ON HISTOPATHOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS JOURNAL OF HEPATOLOGY
Artículo2016 Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis DIGESTIVE AND LIVER DISEASE
Resumen congreso2016 Improvement of carotid intima-media thickness and ankle-brachial index in patients with hepatitis C virus after IFN-free treatment. HEPATOLOGY
Artículo2016 Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study PSYCHOPHARMACOLOGY
Artículo2016 Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate-Induced Liver Injury in Spanish Patients FRONTIERS IN PHARMACOLOGY
Resumen congreso2016 LNCRNA H19 Is Increased In Hepatocellular Carcinoma With Underlying Hcv-Related Cirrhosis HEPATOLOGY
Artículo2016 Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2016 MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C NATURE COMMUNICATIONS
Resumen congreso2016 More than 10 years of experience of use methotrexate in Crohn's disease at Macarena Hospital, Sevilla, Spain JOURNAL OF CROHNS & COLITIS
Resumen congreso2016 More than 10 years of experience of use methotrexate in Ulcerative colitis at Macarena Hospital, Sevilla, Spain JOURNAL OF CROHNS & COLITIS
Resumen congreso2016 Oral glutamine challenge predicts and identifies long-term ammonia-related overt hepatic encephalopathy HEPATOLOGY
Artículo2016 Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Revisión2016 Pharmacogenetics of ribavirin-induced anemia in hepatitis C PHARMACOGENOMICS
Resumen congreso2016 PLPNA3 STATUS IN NASH IS ASSOCIATED WITH INCREASED HISTOLOGICAL SEVERITY AT BASELINE BUT NOT WITH RESPONSE TO THERAPY IN THE GOLDEN-505 ELAFIBRANOR TRIAL JOURNAL OF HEPATOLOGY
Artículo2016 Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry RHEUMATOLOGY INTERNATIONAL
Resumen congreso2016 RELATIONSHIP BETWEEN BASELINE HEPATIC DISEASE SEVERITY AND THE CARDIOMETABOLIC AND ANTI-INFLAMMATORY EFFECTS OF ELAFIBRANOR IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS JOURNAL OF HEPATOLOGY
Artículo2016 Remission maintained by monotherapy after biological plus immunosuppressive combination for Crohn's disease in clinical practice JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Letter2016 Reply to contribution on the topic of hypovitaminosis D in chronic hepatitis C ANNALS OF HEPATOLOGY
Revisión2016 Role of assessing liver fibrosis in management of chronic hepatitis C virus infection CLINICAL MICROBIOLOGY AND INFECTION
Resumen congreso2016 SCCA-IgM helps to identify patients at risk of long-term hepatocelullar carcinoma HEPATOLOGY
Artículo2016 Sedación endoscópica en la cirrosis hepática Revista Andaluza de Patología Digestiva
Resumen congreso2016 Sofosbuvir/Ledipasvir plus Ribavirin achieves high SVR12 in genotype-3 patients with compensated cirrhosis and similar to Sofosbuvir plus Daclatasvir. A multicentre real life cohort HEPATOLOGY
Resumen congreso2016 Spanish Drug-Induced Liver Injury Registry: An update of 20-years prospective collection of idiosyncratic hepatotoxicity cases. HEPATOLOGY
Resumen congreso2016 THE FTO RS1421085 T > C POLYMORPHISM IS ASSOCIATED WITH THE SEVERITY OF NON-ALCOHOLIC FATTY LIVER JOURNAL OF HEPATOLOGY
Resumen congreso2016 TREATMENT OF HEPATITIS C VIRUS IN PATIENTS WITH ADVANCED CIRRHOSIS: ALWAYS JUSTIFIED? ANALYSIS OF THE HEPA-C REGISTRY JOURNAL OF HEPATOLOGY
Artículo2015 28. Impacto de la medición objetiva de comorbilidades en el beneficio de la terapia antiviral libre de interferón en hepatitis C Revista Andaluza de Patología Digestiva
Resumen congreso2015 99.7% Sustained Virologic Response Rate in 369 HCV Genotype 1b-Infected Patients Treated With Label-Recommended Regimen of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2015 Abordaje diagnóstico de la diarrea crónica en adultos Revista Andaluza de Patología Digestiva
Resumen congreso2015 An international, phase 2 randomized controlled trial of the dual PPAR alpha-delta agonist GFT505 in adult patients with NASH HEPATOLOGY
Revisión2015 Assessing cardiovascular risk in hepatitis C: An unmet need World Journal of Hepatology
Artículo2015 Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: Meta-analysis Revista Española de Enfermedades Digestivas
Resumen congreso2015 Beneficial effects of the dual PPAR alpha-delta agonist, GFT505, on hepatic and cardiometabolic markers in adult NASH patients. HEPATOLOGY
Resumen congreso2015 Clinical features and risk factors associated with Non-alcoholic steatohepatitis (NASH) in Spain. On behalf of HEPAmet Registry HEPATOLOGY
Resumen congreso2015 CONTINUUM OF CARE OF HEPATITIS C FROM DETECTION TO CURE: IMPACT OF PEER-TO-PEER SESSIONS IN PRIMARY CARE JOURNAL OF HEPATOLOGY
Resumen congreso2015 CRITICAL FLICKER FREQUENCY PREDICTS SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS JOURNAL OF HEPATOLOGY
Resumen congreso2015 DEVELOPMENT AND VALIDATION OF A SIMPLE CLINICAL PREDICTION MODEL TO IDENTIFY PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS RESOLUTION AFTER 52 WEEKS OF LIFESTYLE MODIFICATION JOURNAL OF HEPATOLOGY
Artículo2015 Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2015 Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Editorial2015 Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field World Journal of Hepatology
Artículo2015 Evolución de la incidencia hospitalaria de la enfermedad inflamatoria intestinal en Andalucía Revista Andaluza de Patología Digestiva
Artículo2015 Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection Genes & Immunity
Resumen congreso2015 FIRST REAL CLINICAL PRACTICE DATA ON SOFOSBUVIR, SIMEPREVIR AND DACLATASVIR WITH HCV-CHRONICALLY INFECTED PATIENTS IN SPAIN: THE HepatiC REGISTRY EXPERIENCE JOURNAL OF HEPATOLOGY
Resumen congreso2015 HCV genotype 3: Meta-analysis with current options HEPATOLOGY
Revisión2015 Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure JOURNAL OF HEPATOLOGY
Artículo2015 Hepatitis C Virus Current and Evolving Treatments for Genotypes 2 and 3 GASTROENTEROLOGY CLINICS OF NORTH AMERICA
Artículo2015 Hepatology highlights ANNALS OF HEPATOLOGY
Artículo2015 High efficacy and safety of triple therapy in hcv genotype 1 and moderate fibrosis: A multicenter study of clinical practice in Spain ANNALS OF HEPATOLOGY
Artículo2015 High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2015 Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients ANNALS OF HEPATOLOGY
Resumen congreso2015 Impact of comorbidities on the benefit of DAA therapy in Hepatitis C HEPATOLOGY
Resumen congreso2015 IMPACT OF PHYSICAL ACTIVITY ON OXIDATIVE STRESS IN PATIENTS WITH HEPATITIS C JOURNAL OF HEPATOLOGY
Resumen congreso2015 INFLUENCE OF METABOLIC RISK FACTORS IN HEPATOTOXICITY (DILI) PHENOTYPE AND OUTCOME JOURNAL OF HEPATOLOGY
Artículo2015 Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease NATURE COMMUNICATIONS
Letter2015 Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis Reply GASTROENTEROLOGY
Resumen congreso2015 METABOLIC RISK FACTORS AFFECT CLINICAL PHENOTYPE AND OUTCOME OF HEPATOTOXICITY (DILI) CLINICAL THERAPEUTICS
Resumen congreso2015 METFORMIN REDUCES HYPERAMMONEMIA IN PORTACAVAL SHUNTED RATS INHIBITING GLUTAMINASE ACTIVITY JOURNAL OF HEPATOLOGY
Artículo2015 Minimal Hepatic Encephalopathy and Critical Flicker Frequency Are Associated With Survival of Patients With Cirrhosis GASTROENTEROLOGY
Artículo2015 Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2015 Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2015 OLIVE OIL COMSUMPTION AMELIORATES NON-ALCOHOLIC STEATOHEPATITIS INDUCED BY HYPERCALORIC AND HYPERLIPIDIC WESTERN DIETS JOURNAL OF HEPATOLOGY
Resumen congreso2015 PHARMACOGENOMIC STUDY TO PREDICT RIBAVIRIN AND PROTEASE-INHIBITOR-RELATED ANEMIA IN HEPATITIS C JOURNAL OF HEPATOLOGY
Artículo2015 Prediction of Week 4 Virological Response in Hepatitis C for Making Decision on Triple Therapy: The Optim Study PLOS ONE
Revisión2015 Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin World Journal of Hepatology
Artículo2015 Profiles and clinical management of hepatitis C patients in Spain: DisHCovery study Revista Española de Quimioterapia
Resumen congreso2015 QUERCETIN MODIFIES LIPID DROPLET MORPHOLOGY AND IMPAIRS HEPATITIS C VIRAL LIFE-CYCLE STEPS FROM ASSEMBLY TO REPLICATION STEPS JOURNAL OF HEPATOLOGY
Artículo2015 Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II) ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Resumen congreso2015 ROLE OF EPIGENETIC FACTORS IN NON-ALCOHOLIC STEATOHEPATITIS DEVELOPMENT JOURNAL OF HEPATOLOGY
Artículo2015 Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment JOURNAL OF CLINICAL VIROLOGY
Artículo2015 Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis LIVER INTERNATIONAL
Editorial2015 Sofosbuvir Modulates the Intimate Relationship Between Hepatitis C Virus and Lipids HEPATOLOGY
Resumen congreso2015 Substantial variability of the diagnostic accuracy of serum fibrosis markers across multiple cohorts of nash patients in various centers : the case for the negative predictive value HEPATOLOGY
Resumen congreso2015 The hepatic and extra-hepatic profile of resolution of steatohepatitis induced by GFT-505 HEPATOLOGY
Capítulo2015 The oral glutamine challenge in liver cirrhosis Glutamine in Clinical Nutrition
Artículo2015 The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity LIVER INTERNATIONAL
Letter2015 Trombosis portal: más allá de la cirrosis hepática GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2015 TYPE 2 DIABETES REDUCES OVERALL SURVIVAL AND INCREASES THE RISK OF HEPATIC DECOMPENSATION IN HCV-RELATED LIVER CIRRHOSIS. RESULTS FROM A PROSPECTIVE LONG-TERM STUDY DURING 8 YEARS JOURNAL OF HEPATOLOGY
Artículo2015 Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program JOURNAL OF VIRAL HEPATITIS
Resumen congreso2015 WEIGHT LOSS INTENSITY IS STRONGLY ASSOCIATED TO IMPROVEMENT OF HISTOLOGICAL PARAMETERS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AFTER 52 WEEKS OF LIFESTYLE MODIFICATION JOURNAL OF HEPATOLOGY
Artículo2015 Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis GASTROENTEROLOGY
Artículo2014 ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV NEW ENGLAND JOURNAL OF MEDICINE
Resumen congreso2014 Altered underlying tubular function in HBV monoinfected patients receiving nucleos(t)ide analogs in a real-world setting: MENTE Study HEPATOLOGY
Resumen congreso2014 ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRY JOURNAL OF HEPATOLOGY
Resumen congreso2014 Bacterial antigen translocation in patients with cirrhosis and minimal hepatic encephalopathy is associated with increased serum ammonia and nitric oxide levels HEPATOLOGY
Resumen congreso2014 CHRONICITY IN IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI): CAUSATIVE DRUGS AND RISK FACTSORS BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Resumen congreso2014 COMPARISONS OF POPULATIONS IN FALDAPREVIR PHASE III STUDIES BASED ON PEGYLATED INTERFERON alpha-2a AND RIBAVIRIN-PREDICTED RESPONSIVENESS AND IMPACT ON ACHIEVING SVR12 JOURNAL OF HEPATOLOGY
Resumen congreso2014 Comparisons of Populations in Faldaprevir Phase III Studies Based on Pegylated Interferon alpha-2A and Ribavirin-Predicted Responsiveness and Impact on Achieving Svr12 GASTROENTEROLOGY
Resumen congreso2014 COST-EFFECTIVENESS ANALYSIS OF ELTROMBOPAG AS SUPPORT TREATMENT IN CHRONIC HCV INFECTED PATIENTS WITH THROMBOCYTOPENIA TO ENABLE INTERFERON-BASED REGIMENS VALUE IN HEALTH
Resumen congreso2014 COST-EFFECTIVENESS ANALYSIS OF TRIPLE THERAPY WITH PEGINTERFERON, RIBAVIRIN, AND BOCEPREVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE 1 WITH SEVERE FIBROSIS UNDER "REAL-LIFE" CONDITIONS VALUE IN HEALTH
Editorial2014 Deciphering the Spectrum of Low-Grade Hepatic Encephalopathy in Clinical Practice GASTROENTEROLOGY
Resumen congreso2014 DETECTION AND DERIVATION RATE AFTER PEER-TO-PEER TRAINING SESSIONS IN PRIMARY CARE ON THE SCREENING OF HEPATITIS B JOURNAL OF HEPATOLOGY
Resumen congreso2014 Early Stopping Rules for Faldaprevir Plus Pegylated Interferon alpha-2A and Ribavirin in Treatment-Naive Patients: Exploratory Study of Pooled Data From Phase III Trials GASTROENTEROLOGY
Resumen congreso2014 EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON alpha-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALS JOURNAL OF HEPATOLOGY
Resumen congreso2014 EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM JOURNAL OF HEPATOLOGY
Resumen congreso2014 Efficacy by Race or Geographic Region in HCV Genotype 1-infected Patients Treated with ABT-450/ritonavir/Ombitasvir and Dasabuvir With or Without Ribavirin HEPATOLOGY
Artículo2014 Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection GASTROENTEROLOGY
Resumen congreso2014 Entecavir has high efficacy and safety in Caucasian patients with chronic hepatitis B and co-morbidities JOURNAL OF VIRAL HEPATITIS
Resumen congreso2014 Faldaprevir Plus Pegylated Interferon/Ribavirin Did Not Increase Anaemia Compared With Pegylated Interferon/Ribavirin in HCV Genotype-1, Treatment-Naive Patients: Pooled Analysis of Phase III Studies GASTROENTEROLOGY
Resumen congreso2014 FALDAPREVIR PLUS PEGYLATED INTERFERON/RIBAVIRIN DID NOT INCREASE ANAEMIA COMPARED WITH PEGYLATED INTERFERON/RIBAVIRIN IN HCV GENOTYPE-1, TREATMENT-NAIVE PATIENTS: POOLED ANALYSIS OF PHASE III STUDIES JOURNAL OF HEPATOLOGY
Resumen congreso2014 FINE MAPPING OF THE BUTYROPHILIN GENOMICS REGION: ROLE IN HEPATITIS C VIRUS INFECTION (HCV) JOURNAL OF HEPATOLOGY
Resumen congreso2014 GLUTAMINASE GENE ALTERATION DETERMINES THE ABILITY TO PREDICT OVERT HEPATIC ENCEPHALOPATHY BOUTS BY CRITICAL FLICKER FREQUENCY AND ORAL GLUTAMINE CHALLENGE JOURNAL OF HEPATOLOGY
Revisión2014 HCV genotype 3 - the new treatment challenge ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2014 Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro JOURNAL OF VIRAL HEPATITIS
Artículo2014 Hepatotoxicidad inducida por estanozolol Revista Andaluza de Patología Digestiva
Artículo2014 Hepatotoxicity associated with statin use: Analysis of the cases included in the Spanish Hepatotoxicity Registry Revista Española de Enfermedades Digestivas
Resumen congreso2014 HERBALS AND DIETARY SUPPLEMENT (HDS) PRODUCTS: A GROWING CAUSE OF HEPATOTOXICITY IN THE SPANISH DILI REGISTRY BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Letter2014 Hypoxic hepatitis as diabetic ketoacidosis complication Revista Española de Enfermedades Digestivas
Artículo2014 IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection JOURNAL OF HEPATOLOGY
Artículo2014 Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Revisión2014 Irisin, a Link among Fatty Liver Disease, Physical Inactivity and Insulin Resistance INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Resumen congreso2014 Killer Ig-like receptors (KIR) profiles and HLA class I ligands in amoxicillin-clavulanate-induced hepatotoxicity HEPATOLOGY
Artículo2014 Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection NEW ENGLAND JOURNAL OF MEDICINE
Resumen congreso2014 LOSS OF GATA4 IN HEPATIC STELLATE CELLS PROMOTES LIVER FIBROSIS JOURNAL OF HEPATOLOGY
Resumen congreso2014 Low Incidence of Hyperbilirubinemia Events With ABT-450/r-Ombitasvir and Dasabuvir With or Without Ribavirin in HCV Genotype-1 Infected Patients AMERICAN JOURNAL OF GASTROENTEROLOGY
Resumen congreso2014 META-ANALYSIS: ROLE OF INSULIN SENSITIZERS ADDED TO PEGINTERFERON AND RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C JOURNAL OF HEPATOLOGY
Resumen congreso2014 Metformin reduces hyperammonemia in portacaval shunted rats inhibiting intestinal glutaminase activity HEPATOLOGY
Resumen congreso2014 NON-INVASIVE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE JOURNAL OF HEPATOLOGY
Artículo2014 Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats JOURNAL OF HEPATOLOGY
Artículo2014 PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C ANNALS OF HEPATOLOGY
Artículo2014 Polycystic liver in the adult (PLA) in Spain: Analysis of a structured survey analysing the experience and attitude of Spanish gastroenterologists Revista Española de Enfermedades Digestivas
Artículo2014 Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2014 PROGNOSTIC MODEL FOR PREDICTING DRUG-INDUCED ACUTE LIVER FAILURE JOURNAL OF HEPATOLOGY
Resumen congreso2014 Protease inhibitors impair renal function in HCV-infected immunocompetent patients HEPATOLOGY
Resumen congreso2014 Quercetin inhibits both replication and assembly of hepatitis C virus by blocking the viral NS3 and the host diacylglycerol acyltransferase type 1 HEPATOLOGY
Resumen congreso2014 QUERCETIN MODULATES LIPIDS DROPLETS IN Huh7 CELLS BEARING PNPLA3 GENOTYPE GG JOURNAL OF HEPATOLOGY
Artículo2014 Randomized clinical trial comparing high versus standard dose of ribavirin plus peginterferon alfa-2a in hepatitis C genotype 3 and high viral load. Dargen-3 study GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2014 Regulation of the akt/mtor pathway by metformin in hepatocellular carcinoma development upon hcv infection JOURNAL OF HEPATOLOGY
Letter2014 Reply to: "Renal impairment and anemia during triple therapy" JOURNAL OF HEPATOLOGY
Resumen congreso2014 Risk factors for chronicity in idiosyncratic drug-induced liver injury (DILI) HEPATOLOGY
Artículo2014 Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol LIFE SCIENCES
Artículo2014 Síndrome LPAC secundario a deleción del exón 4 del gen ABCB4 en un paciente con hepatitis C Revista Española de Enfermedades Digestivas
Artículo2014 Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3 NEW ENGLAND JOURNAL OF MEDICINE
Editorial2014 Stanozolol-induced bland cholestasis GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2014 Statins and metformin use improve prognosis after diagnosis of hepatocelullar carcinoma HEPATOLOGY
Resumen congreso2014 Statins interfere on TCTP and PI3K/AKT/mTOR pathway and inhibit hepatocellular carcinoma progression HEPATOLOGY
Resumen congreso2014 SVR12 of 99% achieved with a ribavirin-free regimen ABT-450/R/ombitasvir and dasabuvir in HCV genotype 1b-infected patients JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Resumen congreso2014 SVR12 of 99% Achieved With a Ribavirin-Free Regimen of ABT-450/r/Ombitasvir and Dasabuvir in HCV Genotype 1b-Infected Patients AMERICAN JOURNAL OF GASTROENTEROLOGY
Resumen congreso2014 TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH MODERATE FIBROSIS. SPANISH MULTICENTRE STUDY IN CLINICAL PRACTICE JOURNAL OF HEPATOLOGY
Artículo2014 Terapia triple en pacientes con fibrosis avanzada y cirróticos aspectos relevantes en la práctica clínica GASTROENTEROLOGIA Y HEPATOLOGIA
Letter2014 Tetany and convulsions: Onset symptoms in crohn’s disease Revista Española de Enfermedades Digestivas
Artículo2014 THDP17 Decreases Ammonia Production through Glutaminase Inhibition. A New Drug for Hepatic Encephalopathy Therapy PLOS ONE
Resumen congreso2014 THE ROLE OF KILLER IG-LIKE RECEPTORS (KIR) AND HLA CLASS I PROFILES IN IDIOSYNCRATIC HEPATOTOXICITY BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Artículo2014 Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury GASTROENTEROLOGY
Resumen congreso2013 A candidate-gene approach to validation of genetic modifier associations using a large cohort with histologically characterised non-alcoholic fatty liver disease JOURNAL OF HEPATOLOGY
Artículo2013 Algoritmo pronóstico para predecir fallo hepático fulminante en hepatotoxicidad Revista Andaluza de Patología Digestiva
Artículo2013 Análisis de los factores que afectan a la utilidad de la elastografía transitoria en pacientes con cirrosis hepática Revista Andaluza de Patología Digestiva
Artículo2013 Association between vitamin D and hepatitis C virus infection: A meta-analysis WORLD JOURNAL OF GASTROENTEROLOGY
Editorial2013 Cirrhosis is less cirrhosis without virus C ANNALS OF HEPATOLOGY
Revisión2013 Clinical management of drug-drug interactions in HCV therapy: Challenges and solutions JOURNAL OF HEPATOLOGY
Resumen congreso2013 Cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients HEPATOLOGY
Ponencia2013 Determination of fibrosis stage and steatohepatitis in patients with nafld by optical analysis of magnetic resonance images combined with artificial neural networks (Fibromri and nashmri) JOURNAL OF HEPATOLOGY
Resumen congreso2013 Early virological response rates in monoinfected patients with HCV and coinfected with HCV/HIV, genotypes 1&4 treated with peginterferon alpha 2a and ribavirin. Optim study JOURNAL OF HEPATOLOGY
Ponencia2013 Efficacy and safety of triple therapy with Peginterferon, Ribavirin, and Boceprevir within Early Access Program in Spanish patients with hepatitis c genotype 1 with severe fibrosis. SVRw12 Analisys HEPATOLOGY
Resumen congreso2013 Efficacy and safety of triple-therapy with peginterferon-ribavirin, and boceprevir as compassionate-use in Spanish patients with hepatitis C genotype 1 with severe fibrosis: Interim-analysis at 12 weeks JOURNAL OF HEPATOLOGY
Artículo2013 Esteatohepatitis alcohólica y no alcohólica: ¿quiénes son los pacientes y qué podemos hacer por ellos? GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2013 EUS-guided coil versus cyanoacrylate therapy for the treatment of gastric varices: a multicenter study (with videos) GASTROINTESTINAL ENDOSCOPY
Resumen congreso2013 Functional analysis of the diacylglycerol acyltransferase activity-1 (DGAT1) in the replication of hepatitis C virus: Effect of quercetin JOURNAL OF HEPATOLOGY
Resumen congreso2013 Genetic variants of the Niemann-Pick C1-like 1 cholesterol absorption receptor and response to antiviral therapy in HCV patients HEPATOLOGY
Revisión2013 Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2013 Hepatotoxicidad por el uso ilícito de esteroides anabolizantes: Una serie prospectiva del registro español y latinoamericano Revista Andaluza de Patología Digestiva
Resumen congreso2013 Histological severity independently predicts early atherosclerotic lesions and 10 year cardiovascular risk in NAFLD patients JOURNAL OF HEPATOLOGY
Artículo2013 HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity PLOS ONE
Resumen congreso2013 I148M PNPLA3 variant promotes steatosis according to viral and IL28B genotype but does not affect sustained viral response in patients with hepatitis C JOURNAL OF HEPATOLOGY
Resumen congreso2013 IL28B-based model for prediction of week 4 viral response in peginterferon-alfa2a+ribavirin treated hepatitis C genotype 1&4. Final report week 4 optim study JOURNAL OF HEPATOLOGY
Resumen congreso2013 Illicit use of anabolic androgenic steroids (AAS) for body building and idiosyncratic liver injury (DILI): A prospective series from the Spanish and Latin-American DILI registry BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Artículo2013 Impacto de la realización de sesiones formativas en la detección de la hepatitis b y c en atención primaria (ver tabla) Revista Andaluza de Patología Digestiva
Artículo2013 Implementación clínica de demili®: Una nueva herramienta para la detección de esteatohepatitis y fibrosis avanzada en pacientes con enfermedad hepática por depósito de grasa no alcohólica (EGHNA) Revista Andaluza de Patología Digestiva
Resumen congreso2013 Increased circulating soluble CD36 is associated with advanced steatosis in patients with nonalcoholic fatty liver disease HEPATOLOGY
Resumen congreso2013 Influence of PNPLA3 genotypes on histological features and adiponutrin serum levels in patients with NAFLD HEPATOLOGY
Artículo2013 Influencia de los genotipos de pnpla3 y niveles de adiponutrina sérica en las características histológicas en pacientes con enfermedad hepática por depósito de grasa no alcohólica (EGHNA) Revista Andaluza de Patología Digestiva
Artículo2013 Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Editorial2013 Insulin Resistance, Telaprevir, and Virological Response in Hepatitis C: The Debate Must Go On HEPATOLOGY
Artículo2013 Introduction Enfermedades infecciosas y microbiología clínica
Ponencia2013 KLF12 polymorphism improves ITPA predictability of anemia in hepatitis C treated with peginterferon plus ribavirin HEPATOLOGY
Resumen congreso2013 KLF12 polymorphism rs9543524 predicts anemia in patients with chronic hepatitis C treated with peginterferon and ribavirin JOURNAL OF HEPATOLOGY
Artículo2013 La quercetina inhibe la replicación del virus de la hepatitis c (vhc), modifica el metabolismo lipídico, la morfología de los lipid droplets (lds) y la localización de core. Revista Andaluza de Patología Digestiva
Artículo2013 Las variantes de pnpla3 promueven la esteatosis en función del genotipo viral y la ilb28 sin afectar a la respuesta viral sostenida en pacientes con hepatitis C Revista Andaluza de Patología Digestiva
Revisión2013 Management of anemia induced by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and recommendations JOURNAL OF HEPATOLOGY
Artículo2013 Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Ponencia2013 Metformin reduces plasmatic ammonia in portacaval shunted rats HEPATOLOGY
Artículo2013 Metformina reduce los niveles de amonio plástico en ratas con derivación portocava Revista Andaluza de Patología Digestiva
Letter2013 Mielotoxicidad por la interacción entre azatioprina y alopurinol en paciente con enfermedad de Crohn GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2013 Non-alcoholic steatohepatitis increases the production of antibodies against oxidized LDL, atherosclerosis and cardiovascular risk JOURNAL OF HEPATOLOGY
Artículo2013 Papel de la regulación de la expresión génica y epigenética (micrornas) relacionada con el desarrollo de hepatocarcinoma en un modelo in vitro de infección por el virus de la hepatitis c. Efecto de la metformina Revista Andaluza de Patología Digestiva
Artículo2013 Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2013 Phase II HCVac study of TG4040 immunotherapeutic in combination with PEGIFN alpha 2a and ribavirin in genotype 1 CHC treatment naive patients: SVR24 final results JOURNAL OF HEPATOLOGY
Artículo2013 Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables ANNALS OF HEPATOLOGY
Artículo2013 PROPEL: A randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naive HCV genotype 1/4 patients HEPATOLOGY
Resumen congreso2013 Quercetin inhibits HCV replication by modulating lipid droplets morphology and core protein co-localization HEPATOLOGY
Artículo2013 Role of diabetes mellitus on hepatic encephalopathy METABOLIC BRAIN DISEASE
Resumen congreso2013 Role of gene and microRNAs expression related to hepatocellular carcinoma development in a hcv-induced model in vitro. Effect of metformin JOURNAL OF HEPATOLOGY
Resumen congreso2013 Role of protein tyrosine-phosphatase 1B (PTP1B) activity in HCV-induced hepatocellular carcinoma: An in vitro analysis JOURNAL OF HEPATOLOGY
Resumen congreso2013 Serum levels of PNPLA3 are related to the development of steatohepatitis in non alcoholic fatty liver disease patients HEPATOLOGY
Resumen congreso2013 The HOMA index is a useful tool for risk stratification of advanced fibrotic disease in a large cohort of european NAFLD patients JOURNAL OF HEPATOLOGY
Ponencia2013 Usefulness in clinical practice of NASHMRi for the detection of steatohepatitis in patients with NAFLD HEPATOLOGY
Resumen congreso2013 Validation study of the impact of SNPs from GWAS associated with fibrosis progression in chronic hepatitis C (HCV) HEPATOLOGY
Artículo2012 5. Recidiva tras el cambio de la doble terapia a la monoterapia en la enfermedad de Crohn Revista Andaluza de Patología Digestiva
Ponencia2012 A GENOME-WIDE ASSOCIATION STUDY IDENTIFIED A NOVEL SUSCEPTIBILITY LOCUS GENE PBK (RS 17388536)FOR SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS BEARING IL28B GENOTYPE CC JOURNAL OF HEPATOLOGY
Artículo2012 Análisis de la influencia del polimorfismo 1331T>C ABCB11 en la interacción funcional de los sitios activos de la proteína transportadora bsep y la toxicidad hepática inducida por fármacos (DILI) Revista Andaluza de Patología Digestiva
Ponencia2012 Anti-LDL-oxidized antibodies: a link between NASH and cardiovascular disease HEPATOLOGY
Artículo2012 Determinación de la presencia de esteatohepatitis en enfermedad hepática por depósito de grasa no alcohólica (EHGNA) basado en el análisis óptico de resonancias magnéticas de hígado y redes neurales artificiales (FibroMRi) Revista Andaluza de Patología Digestiva
Ponencia2012 Determination of the presence of Steatohepatitis in Non-Alcoholic Fatty Liver disease based on optical analysis of Liver MRI and artificial neural networks (FibroMRi) HEPATOLOGY
Ponencia2012 Early virological dynamics on genotype 1 & 4 coinfected (HCV/HIV) and monoinfected (HCV) patients treated with peginterferon-alpha 2a plus ribavirin. An interim analysis of the OPTIM study HEPATOLOGY
Ponencia2012 EFFECT OF ABCC2 HAPLOTYPES ON INDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) SUSCEPTIBILITY JOURNAL OF HEPATOLOGY
Artículo2012 Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Ponencia2012 Endoscopic Ultrasound (EUS) -Guided Therapy of Gastric Varices. Results From a Prospective Multicenter Study GASTROINTESTINAL ENDOSCOPY
Artículo2012 Entry of hepatitis C virus into the cell: A therapeutic target WORLD JOURNAL OF GASTROENTEROLOGY
Ponencia2012 FACTORS INVOLVED IN SUSTAINED VIRAL RESPONSE (SVR) ACHIEVEMENT IN PATIENTS WITH FAVORABLE IL28B CC GENOTYPE IN HEPATITIS C JOURNAL OF HEPATOLOGY
Ponencia2012 Genome-Wide Association Analysis Confirms Importance of PNPLA3 and Identifies Novel Variants Associated With Histologically Progressive Steatohepatitis in NAFLD HEPATOLOGY
Artículo2012 HAVCR1 Gene Haplotypes and Infection by Different Viral Hepatitis C Virus Genotypes CLINICAL AND VACCINE IMMUNOLOGY
Ponencia2012 HEPATITIS C VIRUS MODIFIES PROTEIN AND GENE EXPRESSION OF THE INSULIN SIGNALING PATHWAY IN VIVO AND IN VITRO JOURNAL OF HEPATOLOGY
Ponencia2012 HEPATITIS C VIRUS MODIFIES THE EXPRESSION OF MICRO-RNAS ASSOCIATED WITH APOPTOSIS AND METABOLIC SYNDROME IN HUH7.5 CELLS JOURNAL OF HEPATOLOGY
Ponencia2012 HEPATITIS C VIRUS MODULATES LDL RECEPTOR (LDLR) GENE EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS ACCORDING TO VIRAL CLEARANCE JOURNAL OF HEPATOLOGY
Ponencia2012 HIGH VS STANDARD DOSE OF RIBAVIRIN PLUS PEGINTERFERON-ALFA-2A IN CHRONIC HEPATITIS C, GENOTYPE 3 AND HIGH VIRAL LOAD. FINAL RESULTS OF THE DARGEN-3 STUDY JOURNAL OF HEPATOLOGY
Ponencia2012 HLA class I and II alleles influence the amoxicillin-clavulanate hepatotoxicity signature HEPATOLOGY
Artículo2012 Hyperammonemia induced oxidative stress in cirrhotic rats without promoting differential protein expression in the brain cortex: A 2D-DIGE analysis. Advances in Bioscience and Biotechnology
Ponencia2012 IL28B-based model for prediction of early response in patients with hepatitis C genotype 1&4 treated with peginterferon alfa 2a plus ribavirin (P plus R). OPTIM study HEPATOLOGY
Ponencia2012 Influence of IL-28B genotype on efficacy of retreatment with pegifn alfa-2A and ribavirin in patients with chc and failure of previous treatment (agora study): results at week 12 HEPATOLOGY
Artículo2012 Influencia de la enfermedad hepática por hígado graso no alcohólico sobre la enfermedad cardiovascular: Metaanálisis Revista Andaluza de Patología Digestiva
Artículo2012 Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2012 Insulin Resistance Impairs Viral Dynamics Independently of Ethnicity or Genotypes JOURNAL OF CLINICAL GASTROENTEROLOGY
Artículo2012 Interacción entre los genotipos virales y del hospedador influenciados por la infección del virus de la hepatitis C Revista Andaluza de Patología Digestiva
Ponencia2012 Interaction between host and viral genotypes influenced hepatitis C infection HEPATOLOGY
Ponencia2012 INTERACTION BETWEEN RS12979860 POLYMORHISM OF IL28B GENE WITH BASELINE PREDICTIVE FACTORS OF RESPONSE TO TREATMENT IN PATIENTS WITH HEPATITIS C JOURNAL OF HEPATOLOGY
Artículo2012 Invasive pulmonary aspergillosis in a young man with Crohn's disease. Tropical gastroenterology : official journal of the Digestive Diseases Foundation
Artículo2012 La modulación in vitro de la vía de señalización de la insulina afecta a la replicación del virus de la hepatitis C Revista Andaluza de Patología Digestiva
Artículo2012 Manejo actual de la Encefalopatía Hepática Revista Andaluza de Patología Digestiva
Artículo2012 Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy PLOS ONE
Ponencia2012 METFORMIN PREVENTS OVERT HEPATIC ENCEPHALOPATHY (HE) IN CIRRHOTICS: A RETROSPECTIVE OBSERVATIONAL STUDY JOURNAL OF HEPATOLOGY
Ponencia2012 METFORMIN TREATMENT REDUCES HEPATOCELLULAR CARCINOMA (HCC) RISK IN PATIENTS WITH CIRRHOSIS C: A RETROSPECTIVE OBSERVATIONAL STUDY OF TWO INDEPENDENT COHORTS JOURNAL OF HEPATOLOGY
Ponencia2012 miRNAs involved in insulin resistance are regulated in vitro by HCV infection HEPATOLOGY
Ponencia2012 Non-alcoholic fatty liver disease (NAFLD) influences on cardiovascular disease: Meta-analysis HEPATOLOGY
Artículo2012 Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression JOURNAL OF PROTEOME RESEARCH
Ponencia2012 Optical analysis of liver magnetic resonance images based on neural networks for the determination of fibrosis stage and distribution in non-alcoholic fatty liver disease (NAFLD) JOURNAL OF HEPATOLOGY
Artículo2012 Pancreatitis aguda e infección por Salmonella Enteritidis Revista Andaluza de Patología Digestiva
Ponencia2012 PEGINTERFERON ALPHA-2A ACHIEVES HIGHER EARLY VIROLOGICAL RESPONSES (RVR AND CEVR) THAN PEGINTERFERON ALPHA-2B IN CHRONIC HEPATITIS C: META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS (RCT) JOURNAL OF HEPATOLOGY
Artículo2012 Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Ponencia2012 PNPLA3 and DISC1 are associated with steatosis in patients with chronic hepatitis C HEPATOLOGY
Resumen congreso2012 Predictive Factors of Erythema Nodosum and Pyoderma Gangrenosum in a Spanish Cohort of 397 Patients With Inflammatory Bowel Disease GASTROENTEROLOGY
Letter2012 Relationship between H. pylori and hepatitis A virus infection Revista Española de Enfermedades Digestivas
Ponencia2012 Retreatment of patients with Hepatitis C and failure of previous treatment with peg-ifn and RBV (agora study): results at week 12 HEPATOLOGY
Artículo2012 The Hepatitis C Virus Modulates Insulin Signaling Pathway In Vitro Promoting Insulin Resistance PLOS ONE
Revisión2012 Un nuevo escenario terapéutico en el tratamiento de la hepatitis crónica por virus C FARMACIA HOSPITALARIA
Letter2012 Unsedated colonoscopy: an option for some but not for all GASTROINTESTINAL ENDOSCOPY
Ponencia2012 Utility of agora criteria in the decision to re-treat patients with Hepatitis C and failure of previous treatment with peg-ifn and RBV HEPATOLOGY
Ponencia2012 Validation of FibroMax and NAFLDscore in a cohort of NAFLD Spanish patients HEPATOLOGY
Ponencia2012 Vitamin D supplementation influences sustained virological response rate in Hepatitis C: a systematic review and meta-analysis HEPATOLOGY
Editorial2011 APOC3 polymorphisms and non-alcoholic fatty liver disease: Resolving some doubts and raising others JOURNAL OF HEPATOLOGY
Artículo2011 Brain biomolecules oxidation in portacaval-shunted rats LIVER INTERNATIONAL
Editorial2011 Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C ANNALS OF HEPATOLOGY
Artículo2011 Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy JOURNAL OF CROHNS & COLITIS
Ponencia2011 EFFECTS OF CHEMICAL MOIETIES AND POLYMORPHISMS IN THE HUMAN ABC TRANSPORTER ABCB1 (P-GLYCOPROTEIN/MDR1) IN DRUG-INDUCED LIVER INJURY JOURNAL OF HEPATOLOGY
Artículo2011 Endoscopic closure of a rectovaginal fistula combining N-2-butyl-cyanoacrylate (Histoacryl) and Resolution clips ENDOSCOPY
Artículo2011 Experimental models for hepatic encephalopathy Revista Española de Enfermedades Digestivas
Revisión2011 Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment LIVER INTERNATIONAL
Ponencia2011 HCVAC STUDY: ANTIVIRAL ACTIVITY OF TG4040 THERAPEUTIC VACCINE IN GENOTYPE-1 CHRONIC HCV PATIENTS HEPATOLOGY
Artículo2011 Hepatitis C virus and statins: Is there a role? Current Hepatitis Reports
Ponencia2011 HEPATITIS C VIRUS INFECTION ALTERS LIPID METABOLISM DEPENDING ON THE RS12979860 POLYMORPHISM IN THE IL28B GENE JOURNAL OF HEPATOLOGY
Ponencia2011 HOMA1-IR AND HOMA2-IR INDEXES IN IDENTIFYING INSULIN RESISTANCE IN CHRONIC HEPATITIS C HEPATOLOGY
Ponencia2011 IBUPROFEN-ASSOCIATED HEPATOTOXICITY: ANALYSIS OF A CASE SERIES INCLUDED IN THE SPANISH DILI REGISTRY JOURNAL OF HEPATOLOGY
Ponencia2011 IBUPROFEN, A FREQUENT CAUSE OF HEPATOTOXICITY. ANALYSIS OF A CASE SERIES BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Artículo2011 Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin AMERICAN JOURNAL OF GASTROENTEROLOGY
Editorial2011 Insulin resistance and sustained virological response in hepatitis C: from bench to bedside LIVER INTERNATIONAL
Ponencia2011 INSULIN RESISTANCE PREDICTS SUSTAINED VIROLOGICAL RESPONSE INDEPENDENTLY TO IL28B RS12979860 POLYMORPHISM IN TREATED PATIENTS WITH CHRONIC HEPATITIS C HEPATOLOGY
Ponencia2011 INSULIN SENSITIZER USE WAS ASSOCIATED WITH LOWER RATE OF CIRRHOSIS OUTCOMES: HEPATIC ENCEPHALOPATHY AND SPONTANEOUS BACTERIAL PERITONITIS HEPATOLOGY
Artículo2011 La respuesta virológica al tratamiento con adefovir dipivoxil predice el desarrollo de resistencias a largo plazo en pacientes con hepatitis crónica B HBeAg negativo previamente no tratados GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2011 LONG-TERM FOLLOW-UP IN PATIENTS WITH ACUTE DRUG-INDUCED LIVER INJURY (DILI) BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Artículo2011 Meta-analysis: insulin resistance and sustained virological response in hepatitis C ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Ponencia2011 METFORMIN AND RAPAMYCIN INTERACT WITH INSULIN SIGNALLING PATHWAY AND INHIBIT HCV REPLICATION IN VITRO HEPATOLOGY
Artículo2011 Monitoring activities and improvement in the use of antibiotics in Spanish hospitals: results of a national survey Enfermedades infecciosas y microbiología clínica
Ponencia2011 NONINVASIVE ASSESSMENT OF LIVER FIBROSIS BY FORNS INDEX IS A PREDICTIVE FACTOR OF RESPONSE SIMILAR TO HISTOLOGICAL FIBROSIS IN PATIENTS WITH HEPATITIS C HEPATOLOGY
Artículo2011 Obesity and hepatitis C Gastroenterologia y Hepatologia Continuada
Resumen congreso2011 Obesity dependent metabolic signatures associated with nonalcoholic fatty liver disease progression HEPATOLOGY
Ponencia2011 ONCE DAILY ALISPORIVIR (DEB025) PLUS PEGIFNALFA2A/RIBAVIRIN RESULTS IN SUPERIOR SUSTAINED VIROLOGIC RESPONSE (SVR24) IN CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT NAIVE PATIENTS JOURNAL OF HEPATOLOGY
Ponencia2011 Perfiles metabólicos dependientes de la obesidad asociados a la progresión del hígado graso no alcohólico GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2011 Perspectives from Spanish infectious diseases professionals on 2009 A (H1N1) influenza: the third half CLINICAL MICROBIOLOGY AND INFECTION
Ponencia2011 PROTEOMIC ANALYSIS OF HEPATITIS C INFECTION IN AN IN VITRO MODEL REVEALS A POTENTIAL NEW THERAPEUTIC TARGET: TCTP (TRANSCRIPTION CONTROLLED TUMOR PROTEIN) HEPATOLOGY
Ponencia2011 RELATIONSHIP BETWEEN CHEMICAL MOIETIES AND HUMAN ABC TRANSPORTER ABCB1 (P-GLYCOPROTEIN/MDR1) POLYMORPHISMS IN DRUG-INDUCED LIVER INJURY (DILI) BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Ponencia2011 ROLE OF RAPAMYCIN AS MTOR INHIBITOR IN VITRO AND ITS USE IN THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION JOURNAL OF HEPATOLOGY
Artículo2011 Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles GASTROENTEROLOGY
Artículo2011 Talidomida, peginterferón alfa-2b y ribavirina en el tratamiento de pacientes no respondedores con hepatitis crónica C genotipo 1: Estudio piloto Revista Española de Enfermedades Digestivas
Ponencia2011 THDP-17 inhibits selectively the k-type intestinal glutaminase, but not the type-l in vitro and in vivo JOURNAL OF HEPATOLOGY
Ponencia2011 THE INFLUENCE OF AROMATIC SUBSTITUENTS IN THE GLUTATHIONE S-TRANSFERASE M1 AND T1 DETOXIFYING PROCESS AND THE RISK OF DEVELOPING DRUG-INDUCED LIVER INJURY (DILI) BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Ponencia2011 THE INFLUENCE OF AROMATIC SUSTITUENTS IN THE GLUTATHIONE S-TRANSFERASE M1 AND T1 DETOXIFYING PROCESS AND THE RISK OF DEVELOPING DRUG-INDUCED LIVER INJURY (DILI) BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Revisión2011 The role of insulin resistance in HIV/hepatitis C virus-coinfected patients CURRENT OPINION IN HIV AND AIDS
Ponencia2011 THE ROLE OF THE ABCB1 2677G > T,A POLYMORPHISM IN BILIRUBIN SUBSTRATE SPECIFICITY IN DRUG-INDUCED LIVER INJURY (DILI) HEPATOLOGY
Revisión2011 Use of HOMA-IR in hepatitis C JOURNAL OF VIRAL HEPATITIS
Artículo2010 Campylobacter fetus Peritonitis and Bacteremia in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2010 Cronkhite-Canada syndrome: a new case report of this enigmatic and infrequent disease Revista Española de Enfermedades Digestivas
Artículo2010 Diagnóstico mediante ultrasonografía endoscópica-paaf (USE-PAAF) de metástasis pancreática Revista Andaluza de Patología Digestiva
Ponencia2010 Differential protein expression in the cerebellum of portocaval-shunted rats: a dige/ms study JOURNAL OF HEPATOLOGY
Ponencia2010 DOUBLE-BLINDED CROSSOVER TRIAL ANALYZING THE USEFULNESS OF RIFAXIMIN IN THE TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY (MHE): AN INTERIN ANALYSIS JOURNAL OF HEPATOLOGY
Ponencia2010 Efecto del tratamiento con igf-1 en ratas con encefalopatía hepática por derivación portocava GASTROENTEROLOGIA Y HEPATOLOGIA
Letter2010 Gastric inflammatory fibroid polyp Revista Española de Enfermedades Digestivas
Artículo2010 Genética y complicaciones de la cirrosis GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2010 Genome-wide association and high throughput genotype imputation studies confirm a susceptibility locus to hcv infection on 6p22.1-p21.31 JOURNAL OF HEPATOLOGY
Letter2010 Giant gastric fibroid inflammatory polyp Revista Española de Enfermedades Digestivas
Artículo2010 Hepatitis C y síndrome metabólico GASTROENTEROLOGIA Y HEPATOLOGIA
Resumen congreso2010 HLA alleles influence the occurrence and outcome of amoxicillin-clavulanate liver injury in Spanish patients TISSUE ANTIGENS
Ponencia2010 IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI): FOLLOW-UP IN A COHORT OF PATIENTS IDENTIFIED IN 24 TERTIARY CARE CENTRES IN SPAIN JOURNAL OF HEPATOLOGY
Ponencia2010 IGF-1 replacement therapy in rats with hepatic encephalopathy induced by portacaval shunt JOURNAL OF HEPATOLOGY
Ponencia2010 IL28B GENETIC VARIANTS AND HEPATITIS VIRUS INFECTION BY DIFFERENT VIRAL GENOTYPES JOURNAL OF HEPATOLOGY
Resumen congreso2010 IL28B POLYMORPHISM PREDICTS SUSTAINED VIROLOGICAL RESPONSE IN HEPATITIS C BUT IS NOT ASSOCIATED WITH FIBROSIS OR VIRAL LOAD HEPATOLOGY
Resumen congreso2010 IL28B RS12979860 SNP is associated with lipids metabolism, viral genotype and spontaneous viral clearance in hepatitis C HEPATOLOGY
Ponencia2010 IMPORTANCE OF HOST GENETIC FACTOR, HLA AND IL28B, AS PREDICTORS OF RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C HEPATOLOGY
Ponencia2010 INADECUATE COMPENSATION BY GLUTAMINE SYNTHETASE AND INCREASED GLUTAMINASE ACTIVITY CONTRIBUTES TO HYPERAMMONAEMIA IN CIRRHOSIS HEPATOLOGY
Artículo2010 Insulin Resistance and Response to Antiviral Therapy in Chronic Hepatitis C: Mechanisms and Management Digestive Diseases
Artículo2010 Insulin resistance in chronic hepatitis C Gastroenterologia y Hepatologia Continuada
Resumen congreso2010 Insulin signalling can be blocked in huh7.5 cells transfected with jfh1 by ptpb1 over-expression HEPATOLOGY
Ponencia2010 Interaction between chemical structures and genetic variability in the hepatocellular transporter bile salt export pump (bsep) as a susceptibility factor to idiosyncratic drug-induced liver injury (dili) HEPATOLOGY
Artículo2010 Interleukin-28B Genetic Variants and Hepatitis Virus Infection by Different Viral Genotypes HEPATOLOGY
Letter2010 Metformin Improves Sustained Virologic Response in Difficult-to-Cure Hepatitis C: More Questions than Answers Reply HEPATOLOGY
Artículo2010 Mitochondrial Superoxide Dismutase and Glutathione Peroxidase in Idiosyncratic Drug-Induced Liver Injury HEPATOLOGY
Letter2010 Observed and Calculated Interleukin-28B Genotype Frequencies in Hepatitis C Virus Infection Reply HEPATOLOGY
Ponencia2010 Optical analysis of liver magnetic resonance images for the determination of the stage and distribution of fibrosis in non-alcoholic fatty liver disease HEPATOLOGY
Ponencia2010 P-21. Un microsatélite en la región promotora del gen GLS predice el riesgo de la encefalopatía hepática. Análisis funcional "in vitro" GASTROENTEROLOGIA Y HEPATOLOGIA
Póster2010 P-26. Expresión diferencial de proteínas en cerebelo de ratas con derivación porto-cava: un estudio dige/ms GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2010 P-33. Utilidad de la rifaximina en el tratamiento de la encefalopatía hepática mínima: Análisis intermedio GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2010 P-78. Tratamiento de la resistencia a la insulina con metformina antes de la terapia antiviral con peginterferón y ribavirina en la hepatitis crónica c. estudio piloto GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2010 Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response AMERICAN JOURNAL OF GASTROENTEROLOGY
Corrección2010 Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response (vol 105, pg 2164, 2010) AMERICAN JOURNAL OF GASTROENTEROLOGY
Revisión2010 Pharmacotherapy of hepatic encephalopathy in cirrhosis EXPERT OPINION ON PHARMACOTHERAPY
Artículo2010 Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
Ponencia2010 Relationship between chemical moieties and genetic variability in the canalicular transporter bile salt export pump (bsep) as a susceptibility factor to idiosyncratic drug-induced liver injury (dili) EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Ponencia2010 Relevancia del polimorfismo funcional de la manganeso superóxido dismutasa (SOD2 VAL16ALA ) y de la glutatión peroxidasa 1 (GPX1 PRO200LEU) en pacientes con daño hepático idiosincrásico inducido por medicamentos (DILI) GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2010 Serum Metabolic Signature of Minimal Hepatic Encephalopathy by H-1-Nuclear Magnetic Resonance JOURNAL OF PROTEOME RESEARCH
Ponencia2010 THDP-17 inhibits the glutaminase activity in caco-2 cell cultures JOURNAL OF HEPATOLOGY
Ponencia2010 The HLA class i b*1801 allele influences hepatocellular expression of amoxicillin-clavulanate liver damage and outcome in spanish patients JOURNAL OF HEPATOLOGY
Ponencia2010 THE MECHANISM BEHIND SYNERGISTIC ACTION OF LORNITHINE AND PHENYLACETATE TO REDUCE AMMONIA IN CIRRHOTIC RATS HEPATOLOGY
Ponencia2010 Un índice de fibrosis basado en el fibrotac y forns mejora el diagnóstico no invasivo de la fibrosis hepática significativa en hepatitis C GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2010 Variations in the Promoter Region of the Glutaminase Gene and the Development of Hepatic Encephalopathy in Patients With Cirrhosis A Cohort Study Annals of Internal Medicine
Ponencia2010 WOULD IT BE DESIRABLE TO MODIFY THE CUT-OFF POINT FOR DEFINITION OF CHRONICITY IN DRUG-INDUCED LIVER INJURY (DILI)? HEPATOLOGY
Ponencia2010 Would it be desirable to modify the cutoff point in the definition of chronicity in drug-induced liver injury (DILI)? HEPATOLOGY
Ponencia2009 A MICROSATELLITE IN THE PROMOTER REGION OF THE GLS GENE PREDICTS THE RISK OF HEPATIC ENCEPHALOPATHY: FUNCTIONAL ANALYSIS USING LUCIFERASE REPORTER HEPATOLOGY
Ponencia2009 Analisis of causes of response failure in naive patients with chronic hepatitis C receiving peginterferon plus rivavirin HEPATOLOGY
Corrección2009 Analysis of IL-10, IL-4 and TNF-alpha Polymorphisms in Drug-induced liver injury (DILI) and its outcome (vol 49, pg 107, 2008) JOURNAL OF HEPATOLOGY
Artículo2009 Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori Revista Española de Enfermedades Digestivas
Ponencia2009 EL POLIMORFISMO 1331T>C EN LA BOMBA EXPORTADORA DE SALES BILIARES ES UN FACTOR DE SUSCEPTIBILIDAD AL DAÑO HEPATOCELULAR INDUCIDO POR FÁRMACOS. GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2009 Encefalopatía hepática mínima Revista de Gastroenterología de México
Ponencia2009 ESTUDIO DE LA GLUTAMINASA DEPENDIENTE DE FOSFATO POR BLUE-NATIVE PAGE: UNA APROXIMACIÓN PROTEÓMICA GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2009 FREQUENCY OF-24 C > T POLYMORPHISM IN THE HEPATIC CANALICULAR TRANSPORTER ABCC2 GENE IN SPANISH POPULATION BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Ponencia2009 GENOTYPE DISTRIBUTION OF THE HEPATIC CANALICULAR TRANSPORTER ABCC2-24C > T POLYMORPHISM IS NOT RELATED TO DRUG-INDUCED IDIOSYNCRATIC LIVER INJURY (DILI). RELEVANCE OF ETHNIC VARIANTS IN EUROPEANS JOURNAL OF HEPATOLOGY
Corrección2009 Glutathione S-Transferase M1 and T1 Null Genotypes Increase Susceptibility to Idiosyncratic Drug-Induced Liver Injury (vol 48, pg 588, 2008) HEPATOLOGY
Artículo2009 Gut ammonia production and its modulation METABOLIC BRAIN DISEASE
Revisión2009 Hepatitis C virus and diabetes: Epidemiological association and pharmacological intervention Hot Topics in Viral Hepatitis
Ponencia2009 IMPORTANCE OF HLA-DQB1(star)0301 AS PREDICTIVE FACTOR OF SUSTAINED VIROLOGIC RESPONSE (SVR) IN PATIENTS WITH CHRONIC HEPATITISC (CHC), GENOTYPE-1, TREATED WITH PEGINTERFERON (PEGIFN) AND RIBAVIRIN (RBV) JOURNAL OF HEPATOLOGY
Artículo2009 IMPORTANCIA DEL ALELO HLA-DQB1*0301 COMO FACTOR PREDICTIVO DE RESPUESTA VIROLÓGICA MANTENIDA (RVM) EN PACIENTES CON HEPATITIS CRÓNICA C (HCC), GENOTIPO 1, TRATADOS CON INTERFERÓN PEGILADO Y RIBAVIRINA GASTROENTEROLOGIA Y HEPATOLOGIA
Póster2009 INHIBICIÓN DE LA GLUTAMINASA INTESTINAL GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2009 LA DISTRIBUCIÓN GENOTÍPICA DEL POLIMORFISMO -24C>T EN EL TRANSPORTADOR CANALICULAR ABCC2 NO ESTÁ RELACIONADA CON EL DESARROLLO DE TOXICIDAD HEPÁTICA INDUCIDA POR FÁRMACOS (DILI). RELEVANCIA DE SU VARIABILIDAD ÉTNICA EN LA POBLACIÓN EUROPEA. GASTROENTEROLOGIA Y HEPATOLOGIA
Póster2009 LA RESISTENCIA A LA INSULINA CORRELACIONA CON EL GRADIENDE DE PRESIÓN PORTAL (HVPG) Y PREDICE EL RIESGO DE SANGRADO POR VARICES ESOFÁGICAS EN PACIENTES CIRRÓTICOS GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2009 LINGUISTIC AND TRANSCULTURAL VALIDATION OF THE GASTRO-ESOPHAGEAL REFLUX DISEASE QUESTIONNAIRE FOR A SPANISH POPULATION PATIENT REPORTED OUTCOMES
Ponencia2009 MANGANESE SUPEROXIDE DISMUTASE FUNCTIONAL POLYMORPHISM (SOD2 V16A) IS A MAJOR DETERMINANT OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Letter2009 Metformin, Hepatitis C, and Insulin Resistance: Sufficient Evidence? Reply HEPATOLOGY
Revisión2009 Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines LIVER INTERNATIONAL
Ponencia2009 P.06 Una sobrecarga oral de glutamina alterada en pacientes con encefalopatía hepática mínima valorada mediante la medición de la frecuencia de parpadeo (fcp) predice elevado riesgo de encefalopatía y menor supervivencia GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2009 Phenotypic Characterization of Idiosyncratic Drug-Induced Liver Injury: The Influence of Age and Sex HEPATOLOGY
Ponencia2009 POSITIONAL CLONING IN GLS GENE: A MICROSATELLITE IN THE PROMOTER REGION PREDICTS THE RISK OF HEPATIC ENCEPHALOPATHY JOURNAL OF HEPATOLOGY
Ponencia2009 PREDICTIVE FACTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH COMPLETE EARLY VIROLOGICAL RESPONSE TO THE TREATMENT OF HEPATITIS C HEPATOLOGY
Ponencia2009 PREVALENCIA Y FACTORES IMPLICADOS EN LA DETECCIÓN DEL ALCOHOLISMO SUBREPTICIO Revista Española de Enfermedades Digestivas
Ponencia2009 RASTREO MUTACIONAL DEL GEN DE LA GLUTAMINASA: UN MICROSATÉLITE EN EL PROMOTOR DEL GEN PREDICE EL RIESGO DE ENCEFALOPATÍA HEPÁTICA GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2009 RELEVANCE OF MANGANESE SUPEROXIDE DISMUTASE (SOD2 VAL16ALA) AND GLUTATHIONE PEROXIDASE1 (GPX1 PRO198LEU) FUNCTIONAL POLYMORPHISMS IN PATIENTS WITH IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) HEPATOLOGY
Artículo2009 Results of a survey about specific inflammatory bowel disease units in Andalusia Revista Española de Enfermedades Digestivas
Ponencia2009 ROLE OF POLYMORPHIC BILE SALT EXPORT PUMP (BSEP, ABCB11) AND MULTIDRUG-RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2, ABCC2) TRANSPORTERS IN DRUG-INDUCED LIVER INJURY BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Revisión2009 Steatosis and insulin resistance in hepatitis C: A way out for the virus? WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2009 Tema 1: objetivo del tratamiento y valoración de la respuesta Revista Andaluza de Patología Digestiva
Ponencia2009 Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis c patients (trital): proof of concept HEPATOLOGY
Ponencia2009 The combined use of fibroct and forns index improves the non-invasive diagnosis of significant liver fibrosis in hepatitis C HEPATOLOGY
Ponencia2009 Tratamiento de la resistencia a la insulina en la hepatitis c: resultado final del estudio tric-1 GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2009 Treatment of Insulin Resistance with Metformin in Naive Genotype 1 Chronic Hepatitis C Patients Receiving Peginterferon Alfa-2a Plus Ribavirin HEPATOLOGY
Artículo2008 An analysis of the causes, characteristics, and consequences of reexposure to a drug or compound responsible for a hepatotoxicity event Revista Española de Enfermedades Digestivas
Artículo2008 Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome JOURNAL OF HEPATOLOGY
Corrección2008 Analysis of the causes, characteristics and consequences of the reexposure to medicine or compound responsible for an episode of hepatotoxicity (vol 100, pg 278, 2008) Revista Española de Enfermedades Digestivas
Letter2008 Colitis seudomembranosa de origen poco frecuente GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2008 Combined glutathione-s-transferase M1 and T1 genetic polymorphism and susceptibility to develop drug-induced idiosyncratic liver injury (DILI) JOURNAL OF HEPATOLOGY
Artículo2008 Consulta de alta resolución de digestivo en Andalucía: qué es y cómo debe funcionar? Revista Española de Enfermedades Digestivas
Ponencia2008 EFFECT OF SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON PLUS RIBAVIRIN THERAPY ON LIVER RELATED FREE SURVIVAL IN HCV CIRRHOTIC PATIENTS. FACTORS PREDICTING VIROLOGICAL RESPONSE HEPATOLOGY
Artículo2008 Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C JOURNAL OF HEPATOLOGY
Artículo2008 Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2008 Glutathione s-transferase M1 and T1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury HEPATOLOGY
Ponencia2008 GLUTATHIONE-S-TRANSFERASE M1 AND T1 NULL GENOTYPES INCREASE SUSCEPTIBILITY TO IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
Revisión2008 Hepatitis C: cryoglobulinemia and non-Hodgkin lymphoma Revista Española de Enfermedades Digestivas
Ponencia2008 INSULIN RESISTANCE CORRELATES WITH HVPG AND PREDICTS RISK FOR THE DEVELOPMENT OF VARICEAL BLEEDING IN CIRRHOTICS HEPATOLOGY
Resumen congreso2008 INSULIN RESISTANCE CORRELATES WITH HVPG AND PREDICTS RISK FOR THE DEVELOPMENT OF VARICEAL BLEEDING IN CIRRHOTICS HEPATOLOGY
Ponencia2008 Insulin resistance predicts risk for the development of variceal bleeding JOURNAL OF HEPATOLOGY
Ponencia2008 Interim analysis from TRIC-1 a study of metformin with peginterferon alfa-2a and ribavirin in treatment naive genotype 1 chronic hepatitis C with insulin resistance JOURNAL OF HEPATOLOGY
Artículo2008 Mecanismos de resistencia al interferón en la hepatitis C crónica Hepatitis hoy
Ponencia2008 METFORMIN WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN THE TREATMENT OF NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS WITH INSULIN RESISTANCE (TRIC-1): FINAL RESULTS OF A RANDOMIZED AND DOUBLE-BLINDED TRIAL HEPATOLOGY
Artículo2008 Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C HEPATOLOGY
Revisión2008 Pathogenesis and natural course of hepatic steatosis and insulin resistance in patients with hepatitis C Current Hepatitis Reports
Resumen congreso2008 Peginterferon plus ribavirin and sustained virological response on HCV cirrhosis: Effect on liver-related event free survival and factors predicting response: A retrospective multicenter analysis JOURNAL OF HEPATOLOGY
Ponencia2008 POLYMORPHIC BILE SALT EXPORT PUMP TRANSPORTER IS A MAJOR DETERMINANT OF HEPATOCELLULAR DRUG-INDUCED LIVER INJURY HEPATOLOGY
Artículo2008 PTPN22 C1858T Polymorphism and the Outcome of Hepatitis C Virus Infection VIRAL IMMUNOLOGY
Artículo2008 Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon-ribavirin JOURNAL OF CLINICAL VIROLOGY
Ponencia2008 Smoking and hepatitis C: Influence on fibrosis progression and sustained response JOURNAL OF HEPATOLOGY
Ponencia2008 The influence of age and gender in the biochemical expression of idiosyncratic liver injury JOURNAL OF HEPATOLOGY
Ponencia2007 Assessment of fibrosis distribution in patients with chronic hepatitis C using computerperformed optical analysis of CT of the liver (FibroCT (R)) JOURNAL OF HEPATOLOGY
Editorial2007 Caustic esophagitis and gastritis Revista Española de Enfermedades Digestivas
Artículo2007 CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2007 Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon alpha-2a in hepatitis C virus genotype 1 true non-responder patients ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2007 Colangiopatía autoinmune: criterios diagnósticos actuales Revista Andaluza de Patología Digestiva
Artículo2007 Comentario: fumar perjudica seriamente al hígado Revista Andaluza de Patología Digestiva
Editorial2007 Critical flicker frequency: It is time to break down barriers surrounding minimal hepatic encephalopathy JOURNAL OF HEPATOLOGY
Artículo2007 Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis DIGESTIVE AND LIVER DISEASE
Ponencia2007 Genetic, polymorphisms of Il-10, Il-4 and TNF alpha and susceptibility to develop drug-induced idiosyncratic liver injury (DILI) HEPATOLOGY
Ponencia2007 Haplotypes TACG and CACG from glutaminase gene protect against hepatic encephalopathy JOURNAL OF HEPATOLOGY
Ponencia2007 How can we identify HCV genotype 1 patients who may benefit from an extended treatment duration with peginterferon alpha-2a (40kD) plus RBV? JOURNAL OF HEPATOLOGY
Artículo2007 Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: A randomized trial JOURNAL OF VIRAL HEPATITIS
Ponencia2007 Influence of insulin resistance and ribavirin dosage in viral dynamics of patients with chronic hepatitis C genotype 1 treated with peginterferon and ribavirin JOURNAL OF HEPATOLOGY
Ponencia2007 INFLUENCIA DE LA RESISTENCIA A LA INSULINA, FIBROSIS, OBESIDAD Y DOSIS DE RIBAVIRINA EN LA DINAMICA VIRAL EN PACIENTES CON HEPATITIS C GENOTIPO 1 TRATADOS CON PEGINTERFERON Y RIBAVIRINA GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2007 LOS HAPLOTIPOS TACG Y CACG DEL GEN DE LA GLUTAMINASA PROTEGEN FRENTE A LA ENCEFALOPATÍA HEPÁTICA GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2007 MCP-1 promoter and chemokine receptor CCR2 polymorphisms in Spanish patients with chronic hepatitis C TISSUE ANTIGENS
Editorial2007 Pneumatic perforation of the cecum during diagnostic sigmoidoscopy ENDOSCOPY
Artículo2007 Treatment of chronic hepatitis C genotype 1 with peginterferon-alpha 2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Letter2007 Tumor de células granulares cecal y enfermedad de crohn GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2007 Valoración de la distribución de la fibrosis en pacientes con hepatitis C mediante análisis óptico de imágenes de TAC de hígado (FIBROTC) GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2007 Valoración incruenta de la fibrosis en la hepatitis C Hepatitis hoy
Artículo2007 Value of the critical flicker frequency in patients with minimal hepatic encephalopathy HEPATOLOGY
Nota2007 What is the treatment standard of hepatic encephalopathy? Lessons of clinical trials in the treatment of hepatic encephalopathy Gastroenterologia y Hepatologia Continuada
Capítulo2006 1.4. Neuroimagen Tratado SET de Trastornos Adictivos
Artículo2006 Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patients JOURNAL OF HEPATOLOGY
Artículo2006 Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: Is there still a role for these drugs? WORLD JOURNAL OF GASTROENTEROLOGY
Ponencia2006 Amoxicillin-clavulanate (AC) associated hepatotoxicity: Analysis of a single country large cohort prospectively identified JOURNAL OF HEPATOLOGY
Ponencia2006 Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI) JOURNAL OF HEPATOLOGY
Otros2006 Critical evaluation of estimation methods of fibrosis in chronic hepatitis C Gastroenterologia y Hepatologia Continuada
Artículo2006 Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: A prospective series from Spain HEPATOLOGY
Artículo2006 Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C HEPATOLOGY
Letter2006 Different approaches to therapy of esophageal granular cell tumor (Abrikossoff tumor) SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Ponencia2006 Effect of sustained response in the incidence of type 2 diabetes mellitus in chronic hepatitis C HEPATOLOGY
Artículo2006 Hepatitis C and insulin resistance: steatosis, fibrosis and non-response Revista Española de Enfermedades Digestivas
Revisión2006 Hepatitis C and insulin resistance: Steatosis, fibrosis and nonresponse Revista Española de Enfermedades Digestivas
Ponencia2006 HLA-C and KIR genes in hepatitis C virus infection TISSUE ANTIGENS
Artículo2006 Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis AIDS RESEARCH AND HUMAN RETROVIRUSES
Artículo2006 Insulin resistance and hepatitis C WORLD JOURNAL OF GASTROENTEROLOGY
Artículo2006 Insulin resistance as a non-invasive method for the assessment of fibrosis in patients with hepatitis C: a comparative study of biochemical methods Revista Española de Enfermedades Digestivas
Ponencia2006 Insulin resistance in co-infected HCV/HIV patients: A negative factor influencing sustained response to peginterferon plus ribavirin JOURNAL OF HEPATOLOGY
Artículo2006 Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Otros2006 Liver diseases in preliminary pregnancy Gastroenterologia y Hepatologia Continuada
Artículo2006 Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry HEPATOLOGY
Ponencia2006 Peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) for treating chronic hepatitis C genotype 1 in daily clinical practice: Final results of the Heracles project JOURNAL OF HEPATOLOGY
Artículo2006 Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment GASTROENTEROLOGY
Corrección2006 Peginterferon-Alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment (vol 131, pg 451, 2006) GASTROENTEROLOGY
Ponencia2006 Pharmacokinetics and pharmacodynamics of induction doses of peginterferon alpha-2a (40KD) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in HCV genotype 1 patients who failed to respond to interferon/ribavirin JOURNAL OF HEPATOLOGY
Artículo2006 Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis WORLD JOURNAL OF GASTROENTEROLOGY
Ponencia2006 Phosphate-activated glutaminase gene polymorphisms are implied in cirrhosis susceptibility and risk for hepatic encephalopathy HEPATOLOGY
Ponencia2006 Protein oxidation in astrocyte of porto-caval shunted rats: Role of oxidative stress in hepatic encephalopathy JOURNAL OF HEPATOLOGY
Artículo2006 Results of a survey in Andalusian Endoscopy Units Revista Española de Enfermedades Digestivas
Ponencia2006 Sustained response in chronic hepatitis C reduces the risk to develop impaired fasting glucose and/or diabetes mellitus type 2 JOURNAL OF HEPATOLOGY
Artículo2006 Tablas de normalidad de la población española para los tests psicométricos utilizados en el diagnóstico de la encefalopatía hepática mínima MEDICINA CLINICA
Artículo2006 Tratamiento de la hepatitis crónica C por genotipos 2 y 3: revisión sistemática GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2006 Treatment of chronic hepatitis c genotype 1 with peginterferona2a (40 kda) plus ribavirin under routine clinical practice in spain: early prediction of sustained virological response rate ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Ponencia2006 Usefulness of the measurement of critical flicker frequency in the diagnosis of minimal hepatic encephalopathy (MHE) JOURNAL OF HEPATOLOGY
Ponencia2005 Are there differences in sustained virological response (SVR)rates in patients with HCV genotype 2 or 3 infection and persistently 'normal' ALT activity undergoing treatment with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R))? HEPATOLOGY
Ponencia2005 Bcl-2 expression in ductular proloferation induces fibrosis progression promoting activation of hepatic stellate cells in autoimmune cholestasis JOURNAL OF HEPATOLOGY
Ponencia2005 Development and validation of a simple model to predict response to peginterferon plus ribavirin combination therapy in genotype 1 chronic hepatitis C JOURNAL OF HEPATOLOGY
Artículo2005 DRUG-INDUCED LIVER INJURY: AN ANALYSIS OF 461 INCIDENCES SUBMITTED TO THE SPANISH REGISTRY OVER A 10-YEAR PERIOD GASTROENTEROLOGY
Corrección2005 Erratum: Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period (Gastroenterology (2005) 129 (512-521)) GASTROENTEROLOGY
Artículo2005 Estudio comparativo de dos modelos que utilizan parámetros bioquímicos en el diagnóstico no invasivo de la fibrosis hepática en pacientes con hepatitis C MEDICINA CLINICA
Ponencia2005 Fibrosis assessment in hepatitis C by computerper-formed optical analysis of CT of the liver: A novel nowinvasive and useful method JOURNAL OF HEPATOLOGY
Artículo2005 GLUTAMINASA INTESTINAL Y ENCEFALOPATÍA HEPÁTICA. Gastroenterologia y Hepatologia Continuada
Ponencia2005 Glutaminase activity is implicated in the pathogenesis of hyperammonemia in portocaval shunted rats JOURNAL OF HEPATOLOGY
Ponencia2005 Hepatic encephalopathy is more frequent, severe and shortens the survival in HCV/HIV-related cirrhosis JOURNAL OF HEPATOLOGY
Editorial2005 HEPATITIS C: ARE THERE ANY OPTIONS FOR NON-RESPONDERS? Revista Española de Enfermedades Digestivas
Letter2005 HEPATOTOXICIDAD INDUCIDA POR PAROXETINA MEDICINA CLINICA
Artículo2005 HIV coinfection shortens the survival of patients with hepatitis c virus-related decompensated cirrhosis HEPATOLOGY
Artículo2005 HLA-C and KIR genes in hepatitis C virus infection Human Immunology
Ponencia2005 INCIDENCIA DE HEPATOCARCINOMA EN PACIENTES INFECTADOS POR VHC CON CIRROSIS HEPÁTICA DESCOMPENSADA, INFECTADOS O NO POR VIH GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2005 Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients GASTROENTEROLOGY
Ponencia2005 Insulin resistance promotes fibrosis progression and predicts necro-inflammatory activity in patients with non-alcoholic fatty liver disease JOURNAL OF HEPATOLOGY
Ponencia2005 Oral glutamine challenge response is regulated by portal hypertension and systemic inflammatory response JOURNAL OF HEPATOLOGY
Ponencia2005 Preliminary health outcome results of peginterferon alpha-2a (40kDa) plus ribavirin treatment for chronic hepatitis C genotype 1 in daily routine clinical practice: The heracles project JOURNAL OF HEPATOLOGY
Artículo2005 Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy METABOLIC BRAIN DISEASE
Ponencia2004 ASOCIACION ENTRE HLA-B44 Y RESPUESTA SOSTENIDA AL TRATAMIENTO INTERFERON + RIBAVIRINA EN PACIENTES CON HEPATITIS CRONICA POR VIRUS C Inmunología
Artículo2004 Determinación del genotipo del virus de la hepatitis B y detección de mutaciones de resistencia al tratamiento con lamivudina GASTROENTEROLOGIA Y HEPATOLOGIA
Revisión2004 ENCEFALOPATÍA HEPÁTICA. CLASIFICACIÓN Y MANIFESTACIONES CLÍNICAS Gastroenterologia y Hepatologia Continuada
Corrección2004 Erratum: Tumor estromal de localización gástrica (Gastroenterologia y Hepatologia (2004) 27, 7 (429-435)) GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2004 EVALUACIÓN DIAGNÓSTICA Y AVANCES TERAPÉUTICOS EN LA ENCEFALOPATÍA HEPÁTICA Revista Andaluza de Patología Digestiva
Ponencia2004 EXPRESION DE LA GLUTAMINASA FOSFATO DEPENDIENTE INTESTINAL EN LA ENCEFALOPATÍA HEPATICA MINIMA Revista Española de Enfermedades Digestivas
Ponencia2004 FACTORES REGULADORES DE LA PRODUCCION INTESTINAL DE AMONIO Revista Española de Enfermedades Digestivas
Letter2004 Hepatotoxicity induced by clopidogrel JOURNAL OF HEPATOLOGY
Artículo2004 Histologic features of steatohepatitis in patients with a clinical diagnosis of autoirnmune cholestasis DIGESTIVE DISEASES AND SCIENCES
Ponencia2004 HLA class IB44 is associated with sustained response to interferon plus ribavirin therapy in patients with chronic hepatitis C Genes & Immunity
Artículo2004 HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease HEPATOLOGY
Ponencia2004 Increased phosphate-activated glutaminase activity contributes substantially to the hyperammonemia in acute liver failure. HEPATOLOGY
Ponencia2004 Insulin resistance, fibrosis and genotype are predictors of sustained response rate to pegylated interferon plus ribavirin in patients with chronic hepatitis C JOURNAL OF HEPATOLOGY
Artículo2004 Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy JOURNAL OF HEPATOLOGY
Ponencia2004 Longer treatment duration with peginterferon alfa-2A (40kd) (Pegasys (R)) and ribavirin (Copegus (R)) in naive patients with chronic hepatitis C and detectable HCV RNA by week 4 of therapy: Final results of the randomized, multicenter TeraViC-4 study HEPATOLOGY
Revisión2004 Nuevos conceptos en la fisiopatología de la encefalopatía hepática y perspectivas terapéuticas GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2004 Peginterferon alfa-2a (40KD) (Pegasys (R)) and ribavirin (Copegus (R)) in patients infected with HCV genotype 1 who failed to respond to interferon and ribavirin: Final results of the Spanish High-Dose Induction Pilot Trial. HEPATOLOGY
Letter2004 Peritonitis bacteriana espontánea por Streptococcus anginosus GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2004 Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy HEPATOLOGY
Ponencia2004 RELACIÓN ENTRE LA INFECCION CRÓNICA POR VIRUS C Y LOS GENES MCP-1 Y CCR2 Inmunología
Artículo2004 Serum immunological profile in patients with chronic autoimmune cholestasis AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2004 SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C GUT
Ponencia2004 Sustained virological response after prolonged treatment with peginterferon alfa-2a (40kd) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in treatment-naive patients with chronic hepatitis C and detectable HCV RNA after week 4 of therapy: Teravic-4 study JOURNAL OF HEPATOLOGY
Letter2004 Transient Budd-Chiari syndrome due to iatrogenic subcapsular fluid accumulation following thoracocentesis AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2004 Tumor carcinoide ileal y colitis autolimitada GASTROENTEROLOGIA Y HEPATOLOGIA
Letter2004 Tumor estromal de localización gástrica GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2004 Tumour necrosis factor alpha polymorphisms are not involved in the development of steatosis in chronic hepatitis C EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Resumen congreso2004 Usefulness of "Interpolated visualization" in brain Mri of cirrhotic patients as a diagnostic tool of minimal hepatic encephalopathy European Radiology
Letter2003 Bursitis bacteriana espontánea en un paciente con cirrosis hepática MEDICINA CLINICA
Artículo2003 COMPARATIVE STUDY OF THE EFFICACY OF AN INDUCTION DOSE OF INTERFERON-ALFA 2B WITH RIBAVIRIN COMPARED WITH STANDARD COMBINED TREATMENT IN NAIVE PATIENTS WITH CHRONIC HEPATITIS C JOURNAL OF VIRAL HEPATITIS
Ponencia2003 Computer-performed optical analysis of conventional helical CT of the liver could predict liver fibrosis staging in patients with chronic hepatitis C. HEPATOLOGY
Artículo2003 ETIOPATOGENIA Y DIAGNÓSTICO DE LA CIRROSIS BILIAR PRIMARIA Gastroenterologia y Hepatologia Continuada
Artículo2003 Familial mediterranean fever and sterility. Case report Revista Iberoamericana de Fertilidad y Reproducción Humana
Letter2003 Familial Mediterranean fever mimicking Fitz-Hugh-Curtis syndrome AMERICAN JOURNAL OF GASTROENTEROLOGY
Letter2003 Familial Mediterranean fever mimicking Fitz-Hugh-Curtis syndrome [6] AMERICAN JOURNAL OF GASTROENTEROLOGY
Letter2003 Fatigue is associated with high circulating leptin levels in chronic hepatitis C GUT
Letter2003 HEPATITIS AGUDA POR MONTELUKAST MEDICINA CLINICA
Ponencia2003 High-dose peginterferon alfa-2a (40KD) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in patients infected with hepatitis C virus (HCV) genotype 1 who failed to respond to interferon alfa and ribavirin. HEPATOLOGY
Ponencia2003 HLA CLASS I B44 IS ASSOCIATED WITH SUSTAINED RESPONSE TO INTERFERON + RIBAVIRIN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2003 HLA class IB44 is associated with sustained response to interferon plus ribavirin therapy in patients with chronic hepatitis C AMERICAN JOURNAL OF GASTROENTEROLOGY
Resumen congreso2003 Insulin resistance impairs sustained response rate to antiviral therapy in patients with chronic hepatitis C. HEPATOLOGY
Ponencia2003 Interferon alpha-2a in combination therapies for the treatment of chronic hepatitis C in prior non-responders to interferon monotherapy JOURNAL OF HEPATOLOGY
Letter2003 Lansoprazole-induced hepatic dysfunction ANNALS OF PHARMACOTHERAPY
Ponencia2003 Longer treatment duration with peginterferon alfa-2a (40KD) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in naive patients with chronic hepatitis C and detectable HCV RNA by week 4 of therapy: Preliminary results of the TeraVIC-4 study. HEPATOLOGY
Letter2003 Macro-AST as cause of unknown hypertransaminasaemia EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Artículo2003 Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2003 Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Letter2003 Tratamiento de la colitis ulcerosa corticorrefractaria con inflisimab GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2002 Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy JOURNAL OF HEPATOLOGY
Letter2002 Anticoagulation therapy for recent portal vein thrombosis in a patient with liver cirrhosis suffering from variceal rebleeding GASTROENTEROLOGY
Letter2002 Colestasis gravídica con elevación de las transaminasas sugestiva de hepatitis aguda GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2002 FACTORES AGRAVANTES DE LA LESIÓN HEPÁTICA EN LA HEPATITIS CRÓNICA C Revista Andaluza de Patología Digestiva
Ponencia2002 HLA AND TNF POLYMORPHISMS IN SPANISH PATIENTS WITH CHRONIC HEPATITIS C EUROPEAN JOURNAL OF IMMUNOGENETICS
Letter2002 Infliximab induces remission of pyoderma gangrenosum EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Ponencia2002 Oral glutamine challenge correlates with minimal hepatic encephalopathy and predicts overt episodes JOURNAL OF HEPATOLOGY
Artículo2002 Rationale and design of TeraViC-4 study: A phase III, randomized clinical trial to evaluate the effects of treatment duration with peginterferon alfa-2a (40-kDa) and ribavirin in naive patients with chronic hepatitis C virus infection without early virological response at week 4 METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
Ponencia2002 Role of leptin and hepatic stellate cell (HSC) in the development of steatosis in chronic hepatitis C JOURNAL OF HEPATOLOGY
Artículo2002 The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer Revista Española de Enfermedades Digestivas
Artículo2002 TRATAMIENTO MEDICO DE LA PANCREATITIS CRÓNICA Revista Andaluza de Patología Digestiva
Ponencia2002 VIRAL DINAMIC HEPATITIS C IN PATIENTS TREATED WITH PEGILATED INTERFERON PLUS RIBAVIRIN CLINICAL MICROBIOLOGY AND INFECTION
Artículo2001 Flutamide-induced hepatotoxicity: report of a case series Revista Española de Enfermedades Digestivas
Letter2001 Hepatotoxicity induced by fosinopril JOURNAL OF HEPATOLOGY
Resumen congreso2001 Host and viral factors in hepatocyte steatosis detected in chronic hepatitis C JOURNAL OF HEPATOLOGY
Artículo2001 Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption DIGESTIVE AND LIVER DISEASE
Artículo2001 Lesiones del tracto digestivo superior causadas por la ingestión de cáusticos GASTROENTEROLOGIA Y HEPATOLOGIA
Ponencia2001 Oral glutamine challenge in patients with subclinical hepatic encephalopathy JOURNAL OF HEPATOLOGY
Resumen congreso2001 Pathogenesis of hyperintensity in the globus palidus (HIGP) in cirrhotic patients JOURNAL OF HEPATOLOGY
Artículo2001 Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy AMERICAN JOURNAL OF GASTROENTEROLOGY
Ponencia2001 Tratamiento actual de la hepatitis B GASTROENTEROLOGIA Y HEPATOLOGIA
Letter2000 Acute hepatitis after starting zinc therapy in a patient with presymptomatic Wilson's disease HEPATOLOGY
Revisión2000 Acute pancreatitis complicated by a tubercular abscess ANALES DE MEDICINA INTERNA
Artículo2000 Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis JOURNAL OF CLINICAL GASTROENTEROLOGY
Letter2000 Carcinoma anal en la enfermedad de Crohn GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2000 Cartas al Editor MEDICINA CLINICA
Artículo2000 COLITIS ISQUÉMICA POR SUMATRIPTAN Y DIHIDROERGOTAMINA Revista Andaluza de Patología Digestiva
Ponencia2000 HLA antigens in chronic hepatitis C: Relationship with interferon response and severity of liver injury JOURNAL OF HEPATOLOGY
Artículo2000 Intravenous eradication therapy for bleeding gastroduodenal ulcer associated with Helicobacter pylori infection Revista Española de Enfermedades Digestivas
Revisión2000 LINFOMAS DEL TUBO DIGESTIVO. CLASIFICACIÓN Y ASPECTOS HISTOPATOLÓGICOS Revista Andaluza de Patología Digestiva
Ponencia2000 Manganese level in patients with subclinical hepatic encephalopathy (SHE) JOURNAL OF HEPATOLOGY
Artículo2000 Multicenter retrospective study of response to interferon in chronic hepatitis B Revista Española de Enfermedades Digestivas
Letter2000 PAPEL ETIOPATOGÉNICO DEL VIRUS DE LA HEPATITIS C EN EL SÍNDROME ANTIFOSFOLIPÍDICO. CONTESTACIÓN MEDICINA CLINICA
Artículo2000 Prevalence and clinical significance of antibiotic resistance in Helicobacter pylori Revista Española de Enfermedades Digestivas
Ponencia2000 PREVALENCE AND CLINICAL SIGNIFICANCE OF ANTIPHOSPHOLIPID ANTIBODIES (APA) IN VIRAL CHRONIC LIVER DISEASE JOURNAL OF HEPATOLOGY
Artículo2000 Prevalence and clinical significance of antiphospholipid antibodies in chronic hepatitis C MEDICINA CLINICA
Artículo2000 Usefulness of Helicobacter pylori antigens detection in stools for infection diagnosis and confirming eradication MEDICINA CLINICA
Letter1999 Acute cholestatic hepatitis induced by nimesulide [1] Liver
Letter1999 Acute hepatitis during ritodrine therapy [1] MEDICINA CLINICA
Letter1999 Acute hepatitis related to omeprazole AMERICAN JOURNAL OF GASTROENTEROLOGY
Letter1999 Acute hepatitis related to omeprazole [15] AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo1999 Acute liver injury associated with the use of ebrotidine, a new H2- receptor antagonist JOURNAL OF HEPATOLOGY
Letter1999 Acute pancreatitis and retroperitoneal fibrosis Revista Española de Enfermedades Digestivas
Revisión1999 Anti-Sp100 y anti-Gp210 en el diagnóstico de cirrosis biliar primaria en pacientes con colangitis autoinmune GASTROENTEROLOGIA Y HEPATOLOGIA
Letter1999 FIBROSIS RETROPERITONEAL Y PANCREATITIS Revista Española de Enfermedades Digestivas
Letter1999 HEPATITIS AGUDA POR NIMESULIDA: DESCRIPCIÓN DE TRES CASOS MEDICINA CLINICA
Artículo1999 Hepatitis aguda por ritodrina MEDICINA CLINICA
Ponencia1999 HLA class-II antigens in chronic hepatitis C: Relationship with interferon response and severity of liver disease. HEPATOLOGY
Letter1999 Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis AMERICAN JOURNAL OF GASTROENTEROLOGY
Letter1999 Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis [10] AMERICAN JOURNAL OF GASTROENTEROLOGY
Letter1999 Pancreatic abscess due to Streptococcus salivarius after dental manipulation AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo1999 Trombosis portal como primera manifestación trombótica del sindrome antifosfolípido primario Revista Española de Enfermedades Digestivas
Artículo1999 Ulcera ileal y estenosis colónica tipo diafragma por diclofenaco GASTROENTEROLOGIA Y HEPATOLOGIA
Letter1999 UTILIDAD DE LA VITAMINA K EN CIRROSIS HEPÁTICA ATENCION PRIMARIA
Letter1998 Budd-Chiari syndrome and primary myelofibrosis SANGRE
Letter1998 Carcinoma epidermoide de esofago sobre estenosis caustica esofagica GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo1998 Estudio prospectivo sobre la influencia de la hemorragia por ulcus gastroduodenal en los métodos diagnósticos de infección por helicobacter pylori GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo1998 Influencia del embarazo en la infección crónica por el virus C de la hepatitis MEDICINA CLINICA
Ponencia1998 Is subclinical hepatic encephalopathy a condition for further episodes of overt hepatic encephalopathy? HEPATOLOGY
Ponencia1998 Long-term follow-up of patients with chronic hepatitis C and sustained response to interferon therapy. HEPATOLOGY
Letter1998 Pseudomembranous colitis induced by diclofenac JOURNAL OF CLINICAL GASTROENTEROLOGY
Artículo1998 Sarcoidosis, sclerosing cholangitis, and chronic atrophic autoimmune gastritis - A case of infiltrative sclerosing cholangitis JOURNAL OF CLINICAL GASTROENTEROLOGY
Artículo1997 Características clínicas de la enfermedad de Gaucher tipo I en España. Resultados preliminares de una encuesta nacional MEDICINA CLINICA
Letter1997 Un caso de hepatitis aguda E en Sevilla GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo1996 Retrospective multicentric study on the efficacy of alpha interferon in chronic hepatitis C MEDICINA CLINICA
Artículo1987 Malignant and atypical meningiomas: A reappraisal of clinical, histological, and computed tomographic features Neurosurgery
Encefalopatía hepática subclínica: valoración de diferentes métodos diagnósticos y su relación con la fisiopatología (1996)
Dirigida por: José Aguilar Reina
Tesis dirigidas/tutorizadas:26
Fecha lectura Título Rol
30/06/2023 Análisis de factores clinicopatológicos relacionados con metástasis de ganglios linfáticos del cáncer colorrectal en estadio pT1 Tutor/a
26/06/2023 Predictores de reingreso precoz en población con cirrosis hepática Tutor/a, Director/a
21/02/2023 Aplicación clínica de la elastografía por resonancia magnética en la enfermedad hepática crónica Tutor/a, Director/a
16/11/2022 Biopsychosocial profile of non-alcoholic fatty liver disease (NAFLD) associated with liver transplantation and prevention of risk factors Director/a
22/11/2021 Papel de los microARNs en el diagnóstico del carcinoma hepatocelular relacionado con el virus de la hepatitis B y su papel en la regulación del ADN circular covalente cerrado en pacientes con hepatitis B crónic Tutor/a, Director/a
26/02/2021 VASODILATADORES ARTERIALES VERSUS VENOSOS EN EL EDEMA AGUDO DE PULMÓN CON HIPERTENSIÓN ARTERIAL, EN EMERGENCIAS PREHOSPITALARIAS Director/a, Tutor/a
06/09/2019 GENES Y ENCEFALOPATÍA HEPÁTICA: PROPUESTA DE UNA HUELLA GENÉTICA PARA LA VALORACIÓN DEL RIESGO Director/a, Tutor/a
12/12/2018 UTILIDAD DE LA SOBRECARGA ORAL DE GLUTAMINA EN LA PREDICCIÓN DEL RIESGO Y DEL TIPO DE ENCEFALOPATÍA HEPÁTICA Tutor/a, Director/a
11/07/2018 EL ANTÍGENO DE CÉLULAS NEOPLÁSICAS ESCAMOSAS (SCCA) SOLO O FORMANDO EL COMPLEJO SCCA-IGM ES UN BIOMARCADOR PRECOZ DE CARCINOMA HEPATOCELULAR Tutor/a, Director/a
26/09/2017 NON-INVASIVE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE Tutor/a, Director/a
18/03/2016 IMPACTO DE LA REALIZACIÓN DE SESIONES INTERNIVELES EN LA DETECCIÓN, DIAGNÓSTICO Y TRATAMIENTO DE LA HEPATITIS B Director/a
15/02/2016 PAPEL DE LA VÍA DE SEÑALIZACIÓN DE LA INSULINA Y MTOR EN LA INFECCIÓN POR EL VIRUS DE LA HEPATITIS C. IMPLICACIÓN EN EL DESARROLLO DE CARCINOMA HEPATOCELULAR Director/a
25/03/2015 Impacto del ejercicio fisico en pacientes infectados por el virus de la hepatitis c Director/a
09/01/2015 DIABETES MELLITUS: IMPACT ON THE PATHOPHYSIOLOGY, DIAGNOSE AND TREATMENT OF THE HEPATIC ENCEPHALOPATHY Director/a
11/06/2014 INTERACCIÓN ENTRE LA HEPATITIS C Y EL METABOLISMO LIPÍDICO. UNA OPORTUNIDAD TERAPEÚTICA Director/a
07/05/2013 ANÁLISIS DE IMPACTO DE LOS FACTORES GENÉTICO Y METABÓLICOS EN LA TASA DE RESPUESTA VIRAL SOSTENIDA EN PACIENTES CON HEPATITIS CRÓNICA C TRATADOS CON INTERFERON PEGILADOS RIVABIRINA Director/a
20/07/2012 ESTUDIO DE LA INHIBICIÓN DE LA GLUTAMINASA: UNA NUEVA APROXIMACIÓN TERAPEÚTICA EN LA ENCEFALOPATÍA HEPÁTICA Director/a
23/01/2012 Estudio de la oxidación de proteínas en ratas con encefalopatía hepática: una aproximación proteómica Director/a
10/07/2008 APLICACIÓN DE ALGORITMOS DE ESPECTROSCOPÍA ÓPTICA MULTIVOLUMÉTRICA (EOM) AL PROCESADO DE IMÁGENES DE TOMOGRAFÍA COMPUTERIZADA. ESTUDIOS INICIALES DE APLICACIÓN AL ANÁLISIS DEL DAÑO DIFUSO Y A LA PRECLASIFICACIÓ Director/a
25/06/2008 PAPEL DEL IGF-1 EN LA PATOGENIA DE LA ENCEFALOPATIA HEPATICA. ESTUDIO EXPERIMENTAL EN RATAS SOMETIDAS A DERIVACION PORTO-CAVA Director/a
28/03/2008 APROXIMACIÓN PROTEÓMICA CUANTITATIVA DEL ENTEROCITO Y SU RELACIÓN CON LA ENCEFALOPATÍA HEPÁTICA Director/a
21/12/2006 Papel de la hiperamoniemia sobre la actividad glutaminasa en diferentes tejidos y estrés oxidativo en ratas sometidas a derivación porto-cava Director/a
06/07/2006 VALOR DEL DIAGNÓSTICO POR IMAGEN EN EL ESTUDIO DE LA FIBROSIS HEPÁTICA EN PACIENTES CON VHC CRÓNICA Director/a
30/05/2005 ESTUDIO ETIOPATOGÉNICO DE LAS ALTERACIONES EN LA RESONANCIA MAGNÉTICA Y RM ESPECTROSCÓPICA EN LA ENCEFALOPATÍA HEPÁTICA MÍNIMA. RELACIÓN CON LA PRODUCCIÓN INTESTINAL DE AMONIO Director/a
16/06/2004 PAPEL DE LA GLUTAMINASA FOSFATO DEPENDIENTE (EC 3.5.1.2) EN LA PATOGENIA DE LA ENCEFALOPATÍA HEPÁTICA Director/a
26/11/2003 Comparación de una pauta intravenosa frente a terapia oral en la erradicación de Helicobacter Pylori en pacientes afectos de úlcera gastroduodenal sangrante Director/a

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
13/04/2007 12/04/2010 Investigador/a Tratamiento nutricional de la encefalopatia hepatica: Una aproximacion nutrigenomica (P06-CTS-01887) Junta de Andalucía (Plan Andaluz de Investigación) (Autonómico)

Contratos

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
29/09/2021 28/09/2022 Responsable ELF frente a elastografía transitoria en el diagnóstico de fibrosis avanzada en pacientes con Enfernedad hepática metabólica (EHmet) (4272/0934) Siemens Healthcare, S.L.U. (Desconocido)
26/06/2018 25/06/2021 Responsable NASH dynamics: the natural history of NAFLD and the stages transition progression assessment in clinical practice (3398/0934) INTERCEPT PHARMA EUROPE, LTD (Desconocido)
01/06/2018 28/02/2019 Investigador/a Desarrollo y cribado biológico de una librería de compuestos químicos que interactúen sobre dianas terapéuticas claves en la patogenia de la Esteatohepatitis no alcohólica (Non-Alcoholic Fatty Liver Disease, NASH) (3337/0939) CIBER (Desconocido)

Ayudas

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/01/2010 31/12/2011 Investigador/a Study of brain proteins expression in hyperammonemic-rats (an animal model of hepatic encephalopathy): a proteomic approach (DEC2009-0098) Ministerio de Ciencia e Innovación (Nacional)

Transferencia de Conocimiento

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
27/12/2021 30/04/2023 Responsable EHMET-iA: Desarrollo de un nuevo algoritmo mediante inteligencia artificial (IA) para diagnóstico y seguimiento de pacientes con enfermedad hepática metabólica (EHMET) basado en biomarcadores de imagen (PYC20 RE 010 US) Junta de Andalucía (Consejería de Economía, Conocimiento, Empresas y Universidad) (Autonómico)

Patentes

Nº Solicitud Fecha Solicitud Fecha Concesión Nombre
P200900499 23/02/2009 - Marcadores de encefalopatía hepática
E16710221 17/03/2015 08/05/2019 Métodos de análisis óptico computarizado de imágenes de MR (resonancia magnética) para cuantificar o determinar lesiones hepáticas
P200931265 24/12/2009 09/05/2012 Uso de compuesto n-fenil-n'-(3-metil-2-butenil)tiourea para la elaboración de medicamentos destinados al tratamiento de la encefalopatía hepática